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CHAPTER 1: INTRODUCTION 
1.1 Bacterial protein synthesis 
 Translation of genes into proteins happens in two steps. First, the DNA is transcribed 
to messenger RNA (mRNA), a process that is catalyzed by RNA polymerase. Second, 
the mRNA is translated into the encoded protein by a ribonucleoprotein complex called 
the ribosome. Transfer RNA (tRNA) is the biomolecule that connects the genetic code to 
the protein sequence. These tRNAs contain an anticodon that pairs with the codon in the 
mRNA; the amino acid on the 3’ end of each tRNA matches the identity of the codon in 
the mRNA.  
Protein synthesis can also be described in two phases. In phase one, an aminoacyl-
tRNA synthetase (aaRS) will pair its cognate amino acid with its cognate tRNA, in an 
ATP-dependent manner, to form an aminoacyl-tRNA (aa-tRNA) (Figure 1.1A). This 
reaction is generally selective because most aaRSs are specific for both the amino acid 
and the tRNA and discriminate against other potential compounds in the pool of similarly 
structured substrates. In phase two, the aa-tRNA forms a ternary complex with elongation 
factor Tu (EF-Tu) and GTP that then binds to the ribosome where decoding of the mRNA 
occurs, allowing for the polypeptide chain to continue to grow (Figure 1.1B) [1]. 
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Figure 1.1. Bacterial protein biosynthesis. A. Phase one of protein synthesis is 
achieved by the aminoacyl-tRNA synthetases (aaRS), which will aminoacylate a cognate 
tRNA with its cognate amino acid in an ATP-dependent manner to produce an aminoacyl-
tRNA (aa-tRNA). B. In phase two of protein biosynthesis, the aa-tRNA will form a ternary 
complex with GTP and elongation factor Tu (EF-Tu), to be loaded onto the ribosome for 
protein translation [1]. 
 Protein synthesis usually occurs with high accuracy for an organism to survive; 
consequently, there must be twenty sets of correctly aminoacylated tRNAs to read all 
mRNA codons [2]. Each aaRS catalyzes the esterification of its amino acid substrate to 
its cognate tRNA in two steps. In the first step, the aaRS condenses the amino acid with 
ATP to produce an enzyme-bound aminoacyl adenylate (aa-AMP), releasing inorganic 
ATP AMP  
+ PPi 
aaRS 
aa-tRNA 
A. Phase one of protein synthesis 
GTP 
Ternary complex 
B. Phase two of protein synthesis 
Figure	1.1	
Figure 1.1. Bacterial protein biosynthesis. A. Phase one of protein synthesis is 
achieved by the aminoacyl-tRNA synthetases (aaRS), which will aminoacylate a 
cognate tRNA with its cognate amino acid in an ATP-dependent manner to produce 
an aminoacyl-tRNA (aa-tRNA). B. In phase two of protein biosynthesis, the aa-tRNA 
will form a ternary complex with GTP and elongation factor Tu (EF-Tu) which will go 
on to the the ribosome for protein translation. 
Ribosome 
EF-Tu 
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pyrophosphate. In the second step, either the 2’ or 3’ hydroxyl group of the 3’ adenosine 
in the tRNA reacts with this high-energy aa-AMP to produce the aa-tRNA (Figure 1.2) [3]. 
All aaRSs catalyze these same two reactions. Nevertheless, these enzymes are 
separated into two classes (Class I and Class II) based on the structure of their active 
sites [4, 5], offering an ancient example of convergent evolution. A more in-depth review 
of the aaRSs will be discussed in Section 1.7. 
Figure 1.2. Aminoacylation of tRNAs. In the first step, an aaRS reacts with its cognate 
amino acid and ATP to produce an enzyme-bound aminoacyl adenylate (aa-AMP), 
releasing inorganic pyrophosphate. In the second step, either the 2’ or 3’ hydroxyl group 
of the 3’ adenosine in the tRNA reacts with the high-energy aa-AMP to produce the aa-
tRNA [3]. 
1.2 Direct and indirect tRNA aminoacylation 
 Previously, it was generally accepted that, since there are 20 conical amino acids, 
there must be 20 aaRSs, one for each cognate amino acid-tRNA pair. While this 
hypothesis is true for eukaryotes and select bacteria, such as Escherichia coli (E. coli), it 
is generally not true for prokaryotes [4]. Organisms, like E. coli, that contain all 20 aaRSs 
are able to directly aminoacylate their tRNAs with all 20 commonly encoded amino acids 
(Figure 1.2) [3, 4]. For example, asparaginyl-tRNA synthetase (AsnRS) will aminoacylate 
tRNAAsn with asparagine to produce Asn-tRNAAsn.   
 All archaea and many bacteria lack one or more aaRSs, which means they must use 
an indirect path to aminoacylate some tRNAs [2, 6, 7]. Indirect tRNA aminoacylation 
Figu e	1.2	
H3N
R
O-
O
ATP PPi
aaRS H3N
R
O
O
AMP
tRNAaa AMP
aaRS
H3N
R
O
O
tRNAaa
Figure 1.2. Am noacylation of tRNAs. In the first step, an aaRS reacts with its 
cognate amino acid and ATP to produce an enzyme-bound aminoacyl adenylate (aa-
AMP), releasing inorganic pyrophosphate. In th second step, either the 2’ or 3’ 
hydroxyl group of the 3’ adenosine in the tRNA reacts with the high-energy aa-AMP 
to produce the aa-tRNA. 
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proceeds via misacylated tRNAs, which presents a challenge for the fidelity of translation 
of mRNA codons. Most microorganisms lack AsnRS or glutaminyl-tRNA synthetase 
(GlnRS). Organisms that lack either aaRS must use a two-step, indirect pathway to 
biosynthesize Asn-tRNAAsn and Gln-tRNAGln, respectively [2, 4, 7-10] (Figure 1.3). This 
pathway utilizes a non-discriminating aspartyl-tRNA synthetase or a non-discriminating 
glutamyl-tRNA synthetase (ND-AspRS and ND-GluRS) to misacylate Asp-tRNAAsn or 
Glu-tRNAGln, respectively. (Red text indicates misacylation.) These two aaRSs are called 
non-discriminating aaRSs because they have a relaxed specificity for tRNA and are able 
to also misacylate tRNAAsn with Asp  and tRNAGln with Glu, to produce Asp-tRNAAsn and 
Glu-tRNAGln, respectively [6, 8, 10]. In bacteria, these misacylated intermediates are 
converted into the correctly aminoacylated products, Asn-tRNAAsn and Gln-tRNAGln, by a 
heterotrimeric glutamine-dependent amidotransferase called GatCAB [2, 7, 11] (Figure 
1.3). An expanded discussion of GatCAB is the focus of Section 1.3.  
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Figure 1.3. Indirect pathway for the aminoacylation of tRNAAsn and tRNAGln. ND-
AspRS and ND-GluRS produce the misacylated intermediates Asp-tRNAAsn and Glu-
tRNAGln, respectively. Transamidation of these aminoacyl-tRNAs is achieved by an 
amidotransferase, GatCAB [2, 4, 6-11]. 
 Our lab studies indirect tRNA aminoacylation in 3 different pathogens; Helicobacter 
pylori (H. pylori), Staphylococcus aureus (S. aureus), and Mycobacterium smegmatis (M. 
smegmatis)  (Table 1.1). H. pylori was the first organism sequenced that lacked genes 
that encoded both GlnRS and AsnRS [12]. H. pylori utilizes an ND-AspRS to misacylate 
Asp-tRNAAsn, as discussed above [13]. However, H. pylori does not have an ND-GluRS, 
instead it contains a non-cognate aaRS called GluRS2, which only produces Glu-tRNAGln, 
and a cognate, discriminating aaRS called GluRS1, which can only biosynthesize Glu-
tRNAGlu [9, 14]. GluRS2 is found in a small subset of bacteria. H. pylori also lacks 
asparagine synthetase (AsnS), the enzyme responsible for the biosynthesis of 
asparagine [12]. Organisms that lack AsnS use indirect tRNA aminoacylation to 
synthesize asparagine in a tRNA-dependent manner [15]. For example, S. aureus has a 
Figure	1.3	
Figure 1.3. Indirect pathway for the aminoacylation of tRNAAsn and tRNAGln. ND-
AspRS and ND-GluRS produce the misacylated intermediates Asp-tRNAAsn and Glu-
tRNAGln, respectively. Transamidation of these aminoacyl-tRNAs is achieved by an 
amidotransferase, GatCAB. 
tRNAAsn Aspartic 
acid 
ND-AspRS 
AMP + PPi ATP Asp-tRNAAsn 
GatCAB 
Gln + 
ATP 
Glu + 
ADP + Pi 
Asn-tRNAAsn 
tRNAGln Glutamic 
acid 
AMP + PPi ATP Glu-tRNAGln Gln + 
ATP 
Glu + 
ADP + Pi 
Gln-tRNAGln 
ND-GluRS GatCAB 
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functional AsnRS, but lacks AsnS; therefore S. aureus AspRS is non-discriminating and 
is used in indirect tRNA aminoacylation to biosynthesize asparagine on tRNAAsn [16].  
Table 1.1 Examples of microorganisms lacking one or more aaRSs. These 
organisms use indirect tRNA aminoacylation.  
 
 
 
1.3 GatCAB, the bacterial amidotransferase 
Reproduced in part with permission from *Rathnayake, U. M., *Wood, W. N., and 
Hendrickson, T. L. (2017) Indirect tRNA Aminoacylation During Accurate Translation and 
Phenotypic Mistranslation, Curr Opin Chem Biol. 41, 114-122. 
* These two authors contributed equally to this review article and are listed alphabetically. 
Bacterial GatCAB is a heterotrimeric, glutamine-dependent amidotransferase (GAT) 
composed of three subunits: GatA, GatB, and GatC, with two distal active sites in GatA 
and GatB (~40 Å apart) [17]. GatCAB catalyzes three discrete reactions (glutamine 
hydrolysis, phosphorylation, and transamidation) to convert both Asp-tRNAAsn and Glu-
tRNAGln into Asn-tRNAAsn and Gln-tRNAGln, respectively (Reactions 1-3, shown for Asn-
tRNAAsn biosynthesis only) [2] 
Gln + H2O + ATP + Asp-tRNAAsn à Glu + ADP + H2Pi + Asn-tRNAAsn  (Overall reaction) 
Gln + H2O à Glu + +NH4  (Rxn 1, GatA) 
Asp-tRNAAsn + ATP à γ-phosphoryl-Asp-tRNAAsn + ADP   (Rxn 2, GatB) 
γ-phosphoryl-Asp-tRNAAsn + +NH4 à Asn-tRNAAsn + H2Pi   (Rxn 3, GatB) 
 
Organism Missing aaRS Other relevant missing enzyme 
H. pylori AsnRS GlnRS AsnS 
S. aureus  GlnRS AsnS 
M. tuberculosis/ 
smegmatis 
AsnRS GlnRS  
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GatA is homologous to certain amidases [2] and catalyzes the hydrolysis of glutamine 
to produce glutamate and ammonium (Rxn 1). The ammonium is shuttled into an 
ammonia tunnel that connects the GatA and GatB active sites. (This tunnel is discussed 
in greater detail below.) GatB catalyzes the ATP-dependent phosphorylation/activation of 
Asp-tRNAAsn to γ-phosphoryl-Asp-tRNAAsn (Rxn 2). GatB then uses the ammonium 
produced by GatA (deprotonated to ammonia via an unknown mechanism) to convert γ-
phosphoryl-Asp-tRNAAsn to Asn-tRNAAsn (Rxn 3) [2, 7].  
Many enzymes use molecular tunnels to deliver ammonia from a glutaminase active 
site to a downstream active site [18, 19]. Prior to discovery of GatCAB, known ammonia 
tunnels were typically hydrophobic and the common mechanistic assumption was that 
ammonia was passively transferred in its neutral, deprotonated form (NH3), even through 
tunnels with some hydrophilicity [19]. In sharp contrast, GatCAB’s ammonia tunnel, which 
transfers ammonia ~40 Å from GatA to GatB, is lined with highly conserved polar and 
ionic residues and is populated with many ordered water molecules [17]. The 
hydrophilicity of GatCAB’s tunnel highlights the likelihood that this enzyme employs a 
distinct and novel mechanism (compared to other GATs) to transfer ammonia from one 
active site to another. It has been proposed that ammonia migrates through this tunnel 
by interchanging between neutral ammonia and the protonated ammonium cation with 
the tunnel side chains possibly acting as acids and bases [17].   
Two ammonia tunnels in S. aureus GatCAB have been proposed, which will be 
referred to as tunnel I [17] and tunnel II [20], in order of their discovery. Tanaka and 
coworkers proposed tunnel I, in which ammonia delivery through the GatCAB tunnel 
would proceed through a series of protonation and deprotonation steps (Figure 1.4A) 
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[17]. Ammonia transport would rely on the polar and ionic residues and water molecules 
in the GatCAB tunnel acting as general acids or bases for proton relay and as stabilizers 
for hydrogen bond formation. Ammonium (+NH4) would be deprotonated to ammonia 
(NH3) and then protonated back to ammonium repetitively until it reached the GatB active 
site as ammonia (via deprotonation near the end of the tunnel or in the GatB active site 
by an unknown base) [17]. This novel mechanism would distinguish GatCAB from other 
GATs by requiring discrete catalytic steps to occur within the ammonia tunnel [18, 19]. 
Using the H. pylori GatCAB, our lab mutated several amino acids that line ammonia tunnel 
I and performed in vitro kinetic analyses on wild-type and mutant GatCAB variants [21]. 
Mutations near the GatA active site and lining the tunnel (T149A in GatA) and at the 
interface of GatA and GatB (K89R in GatB) caused reductions in the phosphorylation 
kinetics of GatB, indicating there may be interdomain communication. Molecular 
dynamics simulations using S. aureus GatCAB (by Cisneros and Dewage) further 
supported this scenario and led to the identification of a subset of residues in GatCAB 
that likely participate in interdomain communication [21]. 
Using computational methods, Tateno and co-workers proposed tunnel II, which 
begins with a hydrophobic entrance into the tunnel from GatA (not shown) [20]. Tunnels 
I and II converge ~10 Å from the glutaminase active site. Dewage and Cisneros recently 
calculated the potentials of mean force for the passive transport of ammonia along both 
tunnels in S. aureus GatCAB through molecular dynamic stimulations [22]. The free 
energy calculations were much lower for tunnel I than for tunnel II. Their results [22], 
combined with those from mutagenesis [21], argue that tunnel I is the functionally relevant 
tunnel.  
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We went on to identify a catalytic residue in tunnel I as a probable catalytic base to 
first deprotonate ammonium, directing the resultant ammonia to the next location in the 
tunnel (Figure 1.4B) [23]. D185 was identified in GatA (H. pylori numbering), located near 
the T149 entrance residue (Figure 1.4A). D185A and D185N GatCAB mutants showed 
reductions in glutamine hydrolysis and phosphorylation compared to WT GatCAB, while 
their transamidation activities were almost completely disrupted. D185 lies near the top 
of tunnel I (past the branching point from tunnel II) providing additional support for 
GatCAB’s probable use of tunnel I over tunnel II. Most GATs contain largely hydrophobic 
ammonia tunnels and the mechanistic consensus is that ammonia remains deprotonated 
as it migrates through these different tunnels. GatCAB is the first example of a GAT with 
a hydrophilic tunnel. And, to our knowledge, D185 is the first example of a residue that 
serves any direct catalytic role in an ammonia transport tunnel [23]. This discovery offers 
direct evidence for a novel mechanism for ammonia transfer through the GatCAB tunnel 
via a series of protonation and deprotonation steps.  
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Figure 1.4. The hydrophilic ammonia tunnel of GatCAB. A. A rendition of S. aureus 
GatCAB showing tunnel I in black (PDB ID: 2F2A) [17]. B. The GatCAB ammonia tunnel 
connects the GatA and GatB active sites and their reactions together. D185 is proposed 
to act as an active site base to promote ammonia movement into the tunnel. The number 
of deprotonation and protonation events needed inside the tunnel to deliver ammonia to 
the GatB active site, the identity of the final base that deprotonates ammonium to 
ammonia, and the proton transfer steps that restore GatCAB to its resting protonation 
state are all unknown. It is assumed that the phosphate product absorbs the two protons 
released in this reaction to maintain pH homeostasis. In both panels, GatA is colored in 
magenta and GatB is in cyan. GatC is shown in grey in panel A [23, 24]. Figures 
reproduced with permission from Science [17] and Current Opinion in Chemical Biology 
[24]. 
Indirect tRNA aminoacylation and GatCAB play an important role in translational 
fidelity. Normally, the role of GatCAB is to correct the misacylation of Asp-tRNAAsn and 
Glu-tRNAGln to maintain the fidelity of translation. However, Javid and coworkers have 
demonstrated via forward genetic screens that mutations in GatA lead to mistranslation 
Figure	1.4	
B. 
-O
O
N+
H
HH
H
NH3
H
N
+NH2
H2N
-O
O
OH
N
H
H2N+
NH2
GatA (Rxn 1): 
D185 
+NH4 
NH3 
Gln + H2O Glu + +NH4 
GatB (Rxns 2 & 3): 
~40 Å Ammonium/
Ammonia tunnel 
Asp-tRNAAsn + ATP 
Asn-tRNAAsn + H2Pi 
NH3 + H+ 
A. 
γ-phosphoryl-Asp-tRNAAsn  
+ ADP 
Figure 1.4. The hydrophilic ammonia tunnel of GatCAB. A. A rendition of 
Staphylococcus aureus (S. aureus) GatCAB showing tunnel I in black (PDB ID: 2F2A) 
[11]. Reproduced with permission. B. The GatCAB ammonia tunnel connects the 
GatA and GatB active sites and their reactions together. D185 is proposed to act as 
an active site base to promote ammonia movement into the tunnel. The number of 
deprotonation and protonation events needed inside the tunnel to deliver ammonia to 
the GatB active site, the identity of the final base that deprotonates ammonium to 
ammonia, and the proton transfer steps that restore GatCAB to its resting protonation 
state are all unknown. It is assumed that the phosphate product absorbs the two 
protons released in this reaction to maintain pH homeostasis. In both panels, GatA is 
colored in magenta and GatB is in cyan. GatC is shown in grey in panel A.  
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of asparagine and glutamine codons and that these errors can result in an adaptive 
phenotype [25].  They observed that mutations in GatA not only resulted in reduced 
activity of GatCAB but also decreased its expression levels. These mutations also 
increased rates of mistranslation. Specifically, an aspartate insertion at an asparagine 
codon in RNA polymerase, a residue that is important for rifampicin binding in RNAP, 
resulted in the bacterium becoming tolerant to rifampicin [25]. Javid and coworkers 
research demonstrates that the indirect tRNA aminoacylation pathway can be redirected 
under stressful growing environments to allow for low levels of mistranslation at 
asparagine and glutamine codons to be used as a survival mechanism [25, 26].  
1.4 The Asn-transamidosome 
Organisms that use indirect aminoacylation must also prevent the two misacylated 
tRNA intermediates, Asp-tRNAAsn and Glu-tRNAGln, from entering the ribosome where 
they could cause detrimental translational errors [13, 27, 28]. One mechanism is 
discrimination against misacylated tRNAs by EF-Tu [29-31]. However, this alone, cannot 
completely safeguard the genetic code from mistranslation of asparagine and glutamine 
codons for aspartate and glutamate, respectively [13, 27]. Another mechanism relies on 
the formation of a transamidosome, a ribonucleoprotein complex that promotes the 
conversion of these misacylated tRNAs to their correctly aminoacylated tRNAs, while 
sequestering each misacylated tRNA from EF-Tu and the ribosome [32-34]. For example, 
in Thermus thermophilus (T. thermophilus), the Asn-transamidosome, comprised of two 
ND-AspRS, four tRNAAsn, and two GatCAB molecules, simplifies the transfer of Asp-
tRNAAsn from ND-AspRS to GatCAB, presumably limiting misuse of Asp-tRNAAsn in 
translation (Figure 1.5) [32, 33]. The beauty of this structure is that the acceptor arm of 
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tRNAAsn lies in the active site of ND-AspRS where it will be misacylated to Asp-tRNAAsn; 
the acceptor arm can easily rotate into the active site of GatB where it will be 
phosphorylated and transamidated to Asn-tRNAAsn [32, 33]. This Asn-transamidosome 
structure contains four tRNAAsn molecules, two are catalytic and two are scaffolding 
(Figure 1.5). The two scaffolding tRNAAsn help keep the entire structure together once 
the two catalytic tRNAAsn have been converted to Asn-tRNAAsn, when the latter leave the 
transamidosome and go on to the ribosome to be used for translation [33].  
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Figure 1.5. Crystal structure of the Thermus thermophilus Asn-transamidosome.  
This structure is composed of two copies of GatCAB (the GatCAB subunits are shown in 
orange, blue, and magenta, respectively), two dimeric ND-AspRS molecules (yellow), and 
four tRNAAsn molecules (cyan and green). Two of the tRNAAsn molecules are bound as 
scaffold tRNAs (cyan) and the other two tRNAAsn molecules are bound in a catalytic 
conformation (green). PDB: 3KFU [33].  
Efforts to isolate an analogous H. pylori Asn-transamidosome proved to be 
unsuccessful [35, 36]. This observation led to the hypothesis that another protein may be 
required for stable H. pylori Asn-transamidosome complex formation. Our lab discovered 
a protein of unknown function called Hp0100 by mining a published yeast two-hybrid 
assay that mapped out the protein-protein interaction profile of H. pylori [37]. In this 
screen, the likelihood that an observed interaction between two proteins was functionally 
relevant was described by a scoring system, ranging from A through E. An A score 
indicates that the observed interactions are likely to be physiologically relevant in H. pylori 
and a score of E suggests that the observed interaction is an artifact or noise in the two-
Figure	1.5	
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Figure 1.5. Crystal structure of Thermus thermophilus Asn-transamidosome.  
This structure is composed of two copies of AdT (the three subunits are shown in 
blue, orange, and magenta), two dimeric ND-AspRS molecules (yellow), and four 
tRNAAsn molecules (cyan and green). Two of the tRNAAsn molecules are bound as 
scaffold tRNAs (cyan) and the other two tRNAAsn molecules are bound in a catalytic 
conformation (green).12 PDB: 3KFU 
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hybrid assay. In the originally reported protein-protein interaction profile, H. pylori ND-
AspRS was given a B score with Hp0100. Hp0100 showed only weak, transient, or 
erroneous interactions with GatA, one of the two large subunits of GatCAB; this 
interaction was given a D score (Figure 1.6). Since ND-AspRS and GatCAB have 
functional connections [2, 8], we decided to investigate Hp0100 with respect to its 
apparent interactions with H. pylori ND-AspRS and H. pylori GatCAB. 
Figure 1.6. Yeast two-hybrid protein-protein interaction profile of key proteins in H. 
pylori. The interaction between ND-AspRS and Hp0100 was given a B score, whereas 
the interaction between GatCAB and Hp0100 was given a D score [37].  
We determined that Hp0100 is required for stable, tRNA-independent, Asn-
transamidosome formation (Figure 1.7) [34]. In our proposed H. pylori Asn-
transamidosome cycle, ND-AspRS, GatCAB, and Hp0100 come together to form an apo-
transamidosome; tRNAAsn then binds to the complex to form the holo-transamidosome. 
Figure	1.6	
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Figure 1.6. Yeast wo-hybrid protein-prot in interaction profile of key pro eins 
in H. pylori. The interaction between ND-AspRS and Hp0100 was given a B score, 
whereas the interaction between GatCAB and Hp0100 was given a D score.  
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Transfer RNAAsn is misacylated to Asp-tRNAAsn, which is then converted to Asn-tRNAAsn 
by GatCAB. Then, Asn-tRNAAsn is released from the complex to be used by the ribosome 
for translation (Figure 1.7) [34]. It was also observed that Hp0100 increases the catalytic 
efficiency of GatCAB by ~35-fold with Asp-tRNAAsn as a substrate [34] and ~3-fold with 
Glu-tRNAGln as a substrate (unpublished data, ref. Dr. Gayathri Silva’s thesis [38]). 
Figure 1.7. Our proposed cycle for the conversion of Asp-tRNAAsn into Asn-tRNAAsn 
via an Hp0100-dependent Asn-transamidosome. The Asn-transamidosome 
accelerates the transamidation of the misacylated tRNAs by GatCAB and sequesters 
Asp-tRNAAsn [34]. Figure reproduced with permission from The Journal of Biological 
Chemistry [34]. 
 
Figure	1.7	
Figure 1.7. Our proposed cycle of the conversion of Asp-tRNAAsn into Asn-
tRNAAsn via an Hp0100-dependent Asn-transamidosome. The Asn-
transamidosome accelerates the transamidation of the misacylated tRNAs by 
GatCAB and sequesters Asp-tRNAAsn.  
Make	sure	to	credit	this	figure.	
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1.5 Hp0100, an ATPase with two different active sites 
In our initial efforts to characterize Hp0100, Dr. Gayathri Silva discovered that the 
protein sequence and structural model contained two putative ATP-binding motifs. The 
first is an a-adenosine nucleotide hydrolase (AANH) [39] domain. Interestingly, when the 
model of Hp0100 was generated by Rosetta [40], it was built from a structure of 
argininosuccinate synthetase, which contains an N-type ATP pyrophosphatase motif that 
also belongs to the AANH superfamily (cd01986) [39, 41, 42]. Typically, the AANH ATP-
binding motif hydrolyzes ATP to AMP and pyrophosphate. We have unpublished data 
from assays performed with Hp0100 and either Asp-tRNAAsn or Glu-tRNAGln and a-32P-
ATP, where thin layer chromatography (TLC) was used to separate a-32P-ATP, a-32P-
ADP, and a-32P-AMP. Surprisingly, the production of ADP was observed instead of AMP, 
indicating that the AANH-like domain in Hp0100 is an ATPase that hydrolyzes ATP to 
ADP and Pi [38].  
The second putative ATP-binding motif is a P-loop nucleotide-binding motif. This 
ATPase site was discovered from the primary sequence, because P-loops have a 
conserved consensus sequence of GXXXXGK[S/T]  [43]. P-loops are generally involved 
in the hydrolysis of the b-g-phosphate of ATP, i.e. ATP is hydrolyzed to ADP and Pi [43]. 
Dr. Silva made several point mutations in both the AANH domain and the P-loop. The 
mutants were then assayed for ATPase activity using an enzyme-coupled assay [21]. 
Intriguingly, mutations in the AANH domain showed a reduction in activity with Glu-
tRNAGln, compared to its activity with Asp-tRNAAsn. In contrast, mutations made in the P-
loop domain showed a reduction in activity with Asp-tRNAAsn, compared to its activity with 
Glu-tRNAGln [38]. Thus, Hp0100 contains two distinct ATPase sites that are activated by 
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different misacylated-tRNAs: the first is an AANH-like domain that is activated by Glu-
tRNAGln; the second is a P-loop motif that is activated by Asp-tRNAAsn, indicating that 
Hp0100 is the first ATPase with two distinct active sites that are activated by two different 
substrates.  
Chapter 2 of this thesis focuses on the initial characterization of an ortholog of Hp0100 
from S. aureus, called Sa2591. Full-length orthologs of Hp0100 are restricted to the e-
proteobacteria clade; truncated versions, compromising the first 2/3 of the N-terminus of 
Hp0100, are found outside of this clade. In Chapter 2, the ATPase activity of Sa2591 is 
investigated and the results suggest that Sa2591 is a functional ortholog of Hp0100.  
1.6 Sa2591 metal binding and a probable tRNA modifying enzyme  
 The primary sequence of Sa2591 contains a CXXC motif, a known metal-binding 
domain, near the P-loop ATPase domain [44-46]. A model of Sa2591 was generated 
using I-TASSER [47], which showed several other cysteine residues clustered near the 
CXXC motif. Chapter 3 of this thesis focuses on characterizing the metal binding of 
Sa2591 and investigating this protein as a probable epoxyqueuosine reductase, renaming 
Sa2591 as QueH.  
 Recently, through comparative genomics, de Crécy-Lagard and coworkers 
identified members of the domain of unknown function 208 (DUF208) family, including 
Hp0100, Sa2591, and their orthologs, as putatively being involved in queuosine 
biosynthesis [48]. Queuosine is a hypermodifed guanosine base found in 4 different 
tRNAs: tRNAAsn, tRNAAsp, tRNAHis, and tRNATyr [49] in bacteria and eukaryotes. However, 
only bacteria are able to biosynthesize queuosine. (Eukarya acquire this base from their 
environment [49].) In bacteria, de novo synthesis of queuosine is a multistep process. 
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The first 5 steps convert guanosine triphosphate (GTP) to 7-aminomethyl-7-
deazaguanine (preQ1). The last 3 steps occur on the target tRNA [50, 51]. Transfer RNA-
guanine transglycosylase (TGT) catalyzes the exchange of guanine at position 34 in 
target tRNAs with preQ1. Next, S-adenosylmethionine ribosyltransferase-isomerase 
(QueA) catalyzes the reaction of preQ1 to epoxyqueuosine (oQ). The final step is the 
reduction of oQ to Q, which is achieved by QueG, a cobalamin-dependent 
epoxyqueuosine reductase (Figure 1.8) [51, 52]. QueG also contains 2 [4Fe-4S] iron-
sulfur clusters that are used as a redox chain for the reduction of epoxyqueuosine after 
cobalamin has nucleophilically opened the epoxide ring [53, 54].  
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Figure 1.8. Biosynthesis of queuosine. Shown here are the last 3 steps of queuosine 
biosynthesis. Transfer RNA-guanine transglycosylase (TGT) exchanges G34 in the target 
tRNA for PreQ1. QueA catalyzes the reaction of PreQ1 to epoxyqueuosine on the tRNA 
and QueG reduces the epoxide to the final product, queuosine [50-52].  
Many microorganisms lack QueG, but contain TGT, QueA, and queuosine in their 
tRNAs, which led de Crécy-Lagard and coworkers to identify DUF208 as a putative, non-
orthologous replacement for QueG [48]. This group demonstrated by in vivo 
Figure	1.8	
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epoxyqueuosine on the tRNA and QueG reduces the epoxide to the final product, 
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complementation that DUF208 family members can restore queuosine biosynthesis in a 
∆QueG E. coli strain [48]. Both Hp0100 and Sa2591 were tested in this work and 
successfully restored queuosine production. These authors proposed naming the 
DUF208 proteins QueH [48]. de Crécy-Lagard and coworkers did not detect any 
cobalamin associated with QueH, suggesting that QueH uses a mechanism for 
epoxyqueuosine reduction that is distinct from QueG [48].  
Interestingly, two of the protein structures that were used as threading templates by I-
TASSER to generate the model of Sa2591 are tRNA modifying enzymes [47]. The two 
structures are both of 2-thiouridine synthetase (TtuA) from two different organisms, the 
hyperthermophilic archeon Pyrococcus horikoshii (P. horikoshii) and T. thermophilus [45, 
46]. TtuA is responsible for the biosynthesis of 2-thioribothymidine (S2T) at position 54, 
which is found in nearly all tRNAs in thermophilic and hyperthermophilic prokaryotes. 
S2T54 is in the TYC loop and is necessary to stabilize the tRNA at the elevated growth 
temperatures of thermophiles [55, 56]. TtuA belongs to the TtcA protein family, which are 
characterized by having a P-loop ATPase domain and a CXXC metal binding motif near 
each other [44, 56]. While TtuA is the tRNA modifying enzyme and contains sulfur 
transferase activity, there are several other enzymes involved in the biosynthesis of S2T. 
First, the C-terminus of a ubiquitin-like sulfur carrier protein called TtuB must be thiolated 
to become a thiocarboxylate. This reaction is achieved by a persulfide that is generated 
from a cysteine by a cysteine desulfurase [56]. TtuA uses the activated sulfur from the 
thiocarboxylate for sulfur transfer; however, how the activated sulfur atom is transferred 
from TtuB to TtuA has yet to be elucidated (Figure 1.9) [45, 46, 56]. Before sulfur transfer, 
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TtuA uses its P-loop ATPase domain to adenylate the C2 oxygen in the carbonyl of  the 
ribothymidine in the tRNA to activate it for sulfur transfer (Figure 1.9) [46].  
Figure 1.9. Synthesis of 2-thioribothymidine (S2T) by TtuA. TtuA will use the activated 
sulfur atom from the C-terminal thiocarboxylate of TtuB for nucleophilic attack at C2 after 
oxygen activation by ATP [45, 46, 56]. 
Yokoyama and coworkers demonstrated that the 3 conserved cysteines in TtuA, two 
in the CXXC motif near the P-loop domain and a third cysteine that is nearby spatially, 
participate in S2T biosynthesis [45]. They demonstrated activity in vivo because in vitro 
reconstitution of functional protein had not yet been achieved. Tanaka and coworkers 
eventually observed a [4Fe-4S] cluster in the crystal structure of TtuA [46]. This iron-sulfur 
cluster is coordinated by 3 highly conserved cysteine residues, the same 3 cysteines 
implicated by Yokoyama and colleagues for their mechanistic importance. Tanaka and 
coworkers showed that in vitro activity of TtuA requires the oxygen-labile [4Fe-4S] iron-
sulfur cluster for S2T synthesis [46].  
The structural similarities between Sa2591 (S. aureus QueH) and TtuA give insight 
into the mechanism that Sa2591 may use for the reduction of epoxyqueuosine to 
queuosine. This information is important because QueH is not homologous to QueG and 
Figure	1.9	
Figure 1.9. Synthesis of 2-thioribothymidine (S2T) by TtuA. TtuA will use the 
activated sulfur atom from the C-terminal thiocarboxylate of TtuB for nucleophilic 
attack at C2 after oxygen activation by ATP.   
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does not contain cobalamin, therefore it must use a different epoxyqueuosine reduction 
mechanism. In Chapter 3 of this thesis, the metal-binding features and epoxyqueuosine 
reductase activity of Sa2591 are investigated and a mechanism is proposed for this 
reaction.  
1.7 The aminoacyl-tRNA synthetases 
 Chapter 4 focuses on an unexpected discovery that many bacterial aaRSs can 
hydrolyze ATP to ADP and Pi in the presence of deacylated tRNA. Previously the aaRSs 
were only known to catalyze the same two reactions (Figure 1.2, above) [3]. The first 
reaction uses ATP to produce an enzyme-bound aa-AMP, releasing inorganic 
pyrophosphate (PPi). In the second reaction, either the 2’ or 3’ hydroxyl group of the 3’-
end of the tRNA acts as a nucleophile to attack the a-carbonyl of the amino acid, releasing 
AMP and producing the aa-tRNA. 
 Whether the 2’ or 3’ hydroxyl group of the tRNA is used in the second step of tRNA 
aminoacylation depends on the class of aaRS. As mentioned above, the aaRSs are 
divided into two classes, class I and class II, depending on the structures of their active 
site [4, 5, 57]. Class I aaRSs have an active site Rossmann fold and Class II aaRSs have 
a seven-stranded antiparallel b-sheet tertiary fold. The two different classes approach the 
tRNA from different sides: Class I binds the minor groove of the acceptor steam and Class 
II bind the major groove [4, 5]. These two classes can be further categorized into 
subclasses based on structural and functional idiosyncrasies (Table 1.2) [4, 5, 57]. 
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Table 1.2 Classification of the aaRSs.1  
Class I aaRSs Subclass Class II aaRSs Subclass 
ArgRS 1a AlaRS 2a2 
CysRS 1a GlyRS 2a2 
IleRS 1a HisRS 2a 
LeuRS 1a ProRS 2a 
MetRS 1a SerRS 2a 
ValRS 1a ThrRS 2a 
GlnRS 1b AsnRS 2b 
GluRS 1b AspRS 2b 
  LysRS 2b 
TrpRS 1c PheRS 2c 
TyrRS 1c   
1 Standard three letter amino acid codes are used to abbreviate each aaRS. 
2 AlaRS and GlyRS have been classified as Class 2a by some [4, 5, 57] and Class 2c by 
others [4, 5]. We’ve chosen to identify them as Class 2a, based on similarities between 
the structures of their active sites [57].   
 The aaRSs must be able to differentiate between pools of substrates that are 
chemically similar to one another to ensure accurate translation of the proteome [1, 4, 5, 
58]. An aaRS must choose the correct amino acid and the correct tRNA that are both 
cognate to that particular aaRS. For example, IleRS must correctly select for both 
isoleucine and tRNAIle. Since many of the amino acids have similar shapes and sizes and 
all tRNAs have a similar secondary structure, the aaRS have evolved several different 
strategies to circumvent the challenge of selecting both cognate amino acid and tRNA [4, 
5, 58]. Some aaRSs have also evolved mechanisms to recognize a misacylated-
adenylate or misacylated-tRNA and will hydrolyze this incorrect product. Some of these 
different strategies that the aaRSs use to ensure accurate aminoacylation will be 
discussed below.  
The aaRSs primarily use 3 main regions of the tRNA for recognition: the discriminator 
base at position 73, the acceptor stem, and the anticodon trinucleotide [4, 5, 58]. Transfer 
RNAs typically contain several identity elements that are specific for their tRNA-aaRS 
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pair. For example, tRNAAla contains a unique G3-U70 wobble base pair that AlaRS uses 
to distinguish it from other tRNAs [59]. Some tRNAs also contain antideterminants that 
are used to prevent tRNA binding to a non-cognate aaRS. For anticodon recognition, 
many aaRS have an anticodon binding domain that makes significant contacts with the 
cognate tRNA anticodon [4, 5, 58]. Transfer RNAs have also evolved to have modified 
nucleotides, like queuosine, which increase their chemical diversity [60]. The aaRSs use 
a combination of these different recognition elements to choose their cognate tRNA(s) 
over other, non-cognate tRNAs.  
The specificity of an aaRS for its cognate amino acid is also important for accurate 
translation of the genome [1, 4, 5, 58]. Some aaRSs are able to exclude other amino 
acids from their active site based on the structure and size of the amino acid alone. 
However, this substrate selection can be difficult for some aaRSs when similar non-
cognate amino acids are present. For example, IleRS cannot completely discriminate 
between Ile, its cognate amino acid, and valine. Therefore, some aaRSs, like IleRS, have 
evolved proofreading capabilities to eliminate non-cognate amino acids that have been 
activated as activated aa-AMPs or even aminoacylated onto the incorrect tRNA [4, 5, 58, 
61]. These two proofreading mechanisms are called pre-transfer editing and post-transfer 
editing, respectively (Figure 1.10). In pre-transfer editing, the aa-AMP is typically 
transferred to a distinct editing site in the aaRS, where the non-cognate amino acid is 
hydrolyzed from AMP. Post-transfer editing involves the hydrolysis of an amino acids that 
has been misacylated onto the tRNA; this reaction is also catalyzed in a distal active site. 
Figure 1.10 shows an example of these reactions for IleRS, which has both pre- and 
post-transfer editing capabilities for the misactivation and misacylation of valine onto 
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tRNAIle [4, 61-64]. The fidelity of translation is dependent on the specificity of the aaRSs 
to select for the correct substrates. These enzymes use a combination of different 
mechanisms to recognize their cognate tRNA and amino acid and, in certain cases when 
this has failed, some aaRSs are able to edit misacylated products. 
Figure 1.10. Editing functions of IleRS. Valine can be adenylated by IleRS resulting in 
Val-AMP, which will be moved to the pre-transfer editing site where it will be hydrolyzed. 
If tRNAIle binds to IleRS and becomes misacylated to Val-tRNAIle this will be hydrolyzed 
by a post-transfer editing mechanism [4, 61-64]. 
The main function of the aaRSs is to aminoacylate tRNAs for ribosomal translation. 
The aaRSs and aa-tRNAs also have different alternative functions within the cell [4, 5, 
58]. Aminoacyl-tRNAs can act as amino acid donors in several different processes in the 
cell, for example to regulate their own gene expression. Examples include: AlaRS binding 
to its own DNA to prevent transcription [65]; PheRS regulating transcription of the pheS 
gene [66]; and ThrRS regulating translation of itself by a feedback mechanism [67]. 
GluRS can be phosphorylated and, through a cascade of different responses, is linked to 
bacterial persister formation [68]. Deacylated tRNAs can also act as important signaling 
molecules during amino acid starvation. When the concentration of deacylated tRNAs 
rises in the cell, the stringent response is turned on, which signals for the upregulation of 
Figure 1.10
IleRS + Val + ATP IleRS:Val-AMP IleRS + Val-tRNAIle + AMP
Val + AMP Val + tRNAIle
Pre-transfer
editing
Post-transfer
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PPi
H2O H2O
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Figure 1.10. Editing functions of IleRS. Valine can be adenylated by IleRS
resulting in Val-AMP, which will be moved to the pre-transfer editing site where it will
be hydrolyzed. If tRNAIle binds to IleRS and becomes misacylated to Val-tRNAIle this
will be hydrolyzed by a post-transfer editing mechanism.
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enzymes involved in amino acid biosynthesis. Defective aaRS editing functions can have 
a direct effect on the stringent response [69].  
The aaRSs were first characterized in the 1950s and were long thought to only have 
one function in the cell: To aminoacylate tRNAs for translation. As discussed above, 
aaRSs, aa-tRNAs, and even deacylated tRNAs are involved in a diverse array of cellular 
functions. Chapter 4 of this thesis focuses on our discovery of a new, unprecedented 
reaction catalyzed by some aaRSs. We demonstrate that some aaRSs hydrolyze ATP to 
ADP and Pi in the presence of deacylated tRNAs. We screened 25 different aaRSs from 
3 different bacterial species for this activity. In Chapter 4, we make comparisons of rates 
for this activity among the different sub-classes of aaRSs and across species. We also 
discuss different possible roles of this ADP production including a tantalizing possible 
connection to bacterial persistence.  
In conclusion, this thesis describes two research projects that are connected by the 
common theme of tRNA aminoacylation. Chapters 2 and 3 examine Sa2591 for its roles 
in indirect tRNA aminoacylation and, potentially, in queuosine biosynthesis. Chapter 4 
describes the discovery that many aaRSs can produce ADP in the presence of deacylated 
tRNA. The impact of these discoveries will be discussed independently in each chapter 
and more broadly in Chapter 5. 
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CHAPTER 2: A NOVEL PROTEIN FROM STAPHYLOCOCCUS AUREUS, SA2591, IS 
SIMILAR TO HP0100 IN STRUCTURE AND PROBABLE FUNCTION 
2.1 Introduction 
 Protein synthesis typically occurs with high accuracy [2]; consequently, there must be 
twenty sets of correctly aminoacylated tRNAs to read all mRNA codons. However, 
Helicobacter pylori, Staphylococcus aureus, and many other microorganisms lack one or 
more aminoacyl-tRNA synthetase (aaRS), the enzymes that typically catalyze the 
esterification of each amino acid to their cognate tRNAs prior to ribosomal translation [3, 
12, 70]. Many microorganisms lack glutaminyl-tRNA synthetase (GlnRS) and/or 
asparaginyl-tRNA synthetase (AsnRS) [3]. These species use an indirect path to correctly 
aminoacylate tRNAGln and/or tRNAAsn to produce Gln-tRNAGln and Asn-tRNAAsn [2, 4, 7]. 
Indirect tRNA aminoacylation is a two-step pathway that begins with tRNA 
misacylation (step 1), followed by aminoacyl-tRNA transamidation (step 2) to produce the 
desired products (Figure 1.3) [7]. Misacylation of tRNAAsn is achieved by a non-
discriminating aspartyl-tRNA synthetase (ND-AspRS), which produces both Asp-tRNAAsp 
and Asp-tRNAAsn [6, 13]. Glu-tRNAGln is generated by either a non-discriminating 
glutamyl-tRNA synthetase (ND-GluRS, which also makes Glu-tRNAGlu) [10] or a tRNAGln-
specific GluRS2 [9, 14]. The conversion of these misacylated tRNAs (Asp-tRNAAsn and 
Glu-tRNAGln) into the corresponding correctly aminoacylated tRNAs (Asn-tRNAAsn and 
Gln-tRNAGln) is achieved by an amidotransferase called GatCAB [2, 4, 11]. In bacteria, 
GatCAB is typically heterotrimeric [2]. 
In some organisms (e.g. T. thermophilus), ND-AspRS and GatCAB assemble into a 
tRNAAsn-dependent ribonucleoprotein complex called the Asn-transamidosome (Figure 
1.5). This complex promotes the conversion of Asp-tRNAAsn to Asn-tRNAAsn [32, 33]. 
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However, efforts to isolate an analogous H. pylori Asn-transamidosome have been 
unsuccessful [35, 36]. Instead, a tRNA-independent Asn-transamidosome assembles via 
an unusual protein factor called Hp0100 [34]. 
 Our lab previously discovered H. pylori Hp0100, via data-mining of a yeast two-hybrid 
assay (Figure 1.6) [37]. We showed that this protein is required for the tRNA-independent 
H. pylori Asn-transamidosome (Figure 1.7) [34]. Hp0100 accelerates the transamidation 
rate of GatCAB for Asp-tRNAAsn by ~35-fold [34] and for Glu-tRNAGln by ~3-fold 
(unpublished data, ref. Dr. Gayathri Silva’s thesis [38]). We also have remarkable 
unpublished data (Dr. Gayathri Silva [38]) that show that Hp0100 contains two divergent 
ATP hydrolase (ATPase) active sites: the first is an a-adenosine nucleotide hydrolase 
(AANH) [39] domain that is activated by Glu-tRNAGln; the second is a P-loop motif [43], 
wherein ATP hydrolysis is activated by Asp-tRNAAsn. Results from Dr. Gayathri Silva’s 
work on Hp100 is summarized in Figure 2.1 [38].  To our knowledge, this is the first 
ATPase to contain two distinct active sites that are stimulated by two different substrates.
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Figure 2.1. Hp0100 is multifunctional ATPase. Hp0100 is required for tRNA-
independent, Asn-transamidosome formation (top of figure) [34]. Hp0100 increases the 
transamidation rate of Asp-tRNAAsn by 35-fold and that of Glu-tRNAGln by 3-fold [38]. A 
Rosetta model of Hp0100 (bottom of figure) [40] is colored with the a-adenosine 
nucleotide hydrolase (AANH) ATPase domain in magenta and the P-loop ATPase domain 
in blue. ATP hydrolysis by the AANH domain is stimulated by Glu-tRNAGln and the P-loop 
domain is stimulated by Asp-tRNAAsn [38]. 
Our published and unpublished work define a role for Hp0100 and demonstrate that 
proteins involved in central processes like tRNA aminoacylation remain undiscovered. 
Our results also show that the biosynthesis of aminoacylated tRNAs in H. pylori is more 
complex than previously appreciated. Our lab’s discovery of Hp0100, its interactions with 
ND-AspRS and GatCAB, and its impact on GatCAB efficiency offer a precedent for the 
hypothesis that proteins of unknown function can still be discovered to be involved in 
tRNA aminoacylation. Our published [34] and unpublished data [38] are summarized in 
Figure 2.1. 
While full-length orthologs of Hp0100 are unique to the e-proteobacteria, truncated 
versions, comprising approximately 2/3 of the primary sequence of Hp0100, have been 
Figure 2.1
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transamidation rates of Asp-tRNAAsn by 35-fold and that of Glu-tRNAGln by 3-fold. A
Rosetta model of Hp0100 (bottom of figure) is colored with the a-adenosine
nucleotide hydrolase (AANH) ATPase domain in magenta and the P-loop ATPase
domain in blue. ATP hydroly is by the AANH domain is stimulated by Glu-tRNAGln and
the that of the P-loop domain is stimulated by Asp-tRNAAsn.
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found in many different bacteria. Notably, examples of this new variation were identified 
in Neisseria gonorrhoeae (N. gonorrhoeae) and S. aureus, which are both listed by the 
CDC as “biggest threats” to the US [71, 72]. The primary sequences of these proteins all 
contain the two ATPase active sites identified in Hp0100: the AANH domain [39] and a 
P-loop motif [43] (Figure 2.2).  
Figure 2.2. Sequence homology between Hp0100 and Sa2591. A. Cartoon comparing 
the identifiable features in Sa2591 to those in Hp0100. The AANH ATPase domain is 
shown in magenta, the P-loop ATPase domain is shown in blue, and conserved cysteine 
residues are highlighted in orange (See Chapter 3 for additional discussion of these 
cysteines). B. Sequence alignment of the AANH-like domain (top) and the P-loop domain 
(bottom) from Hp0100 and Sa2591. A conserved CXXC motif, in the P-loop, that is a 
putative metal binding site, is boxed in orange. Rigorously conserved residues are labeled 
with an asterisk; highly conserved residues are marked with a colon; and loosely 
conserved residues are marked with a period. 
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comparing the identifiable features in Sa2591 to those in Hp0100. The AANH
ATPase domain is shown in magenta, the P-loop ATPase domain is shown in blue,
and conserved cysteine residues are highlighted in orange. B. Sequence
alignment of the AANH-like domain (top) and the P-loop domain (bottom) from
Hp0100 and Sa2591. A conserved CXXC motif, in the P-loop, that is a putative
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The main focus of this chapter is to describe our efforts to characterize indirect tRNA 
aminoacylation in methicillin-resistant S. aureus (MRSA). MRSA is resistant to first-line 
antibiotics and is a cause for healthcare-associated bloodstream and catheter-related 
infections [71]. MRSA has a viable copy of AsnRS, but it lacks GlnRS, so indirect tRNA 
aminoacylation is required for the biosynthesis of Gln-tRNAGln. This pathogen is also 
missing a gene coding asparagine synthetase (AsnS), the protein that would normally 
biosynthesize asparagine [70]. The absence of AsnS indicates that indirect tRNA 
aminoacylation will utilize ND-AspRS and GatCAB for tRNA-dependent asparagine 
biosynthesis [16]. And, most importantly, MRSA contains a truncated ortholog of Hp0100, 
called Sa2591. We hypothesize that Hp0100 and Sa2591 are functional orthologs, 
despite their different sizes. Sa2591 has proven to be much easier to work with because 
it expresses and purifies from E. coli more readily. When purifying Hp0100, a large portion 
of the protein remains insoluble, which may be due to the extra domain on the C-terminus 
of Hp0100 that is lacking in Sa2591.  For these reasons, we set out to evaluate Sa2591 
to verify that it is structurally and functionally related to Hp0100.  
A cartoon highlighting the identifiable sequences and features of Sa2591 is compared 
to Hp100 in Figure 2.2A. Sa2591 consists of the first 2/3 of Hp0100, including both the 
AANH and P-loop ATPase domains. Both Hp0100 and Sa2591 contain several conserved 
cysteine residues that form a putative metal-binding site. This site is the focus of Chapter 
3 and will be discussed in more detail there. Comparative sequence alignments of the 
AANH domain and P-loop motifs are show in Figure 2.2B. Overall, these two orthologous 
proteins share 29% sequence identity [73]. Structural models of Hp0100 and Sa2591 
were generated using Rosetta [40] and I-TASSER [47], respectively. As expected, the 
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two models showed structural similarity (Figure 2.3). These similarities led us to 
hypothesize that Sa2591 may function in a similar way to Hp0100.  
Figure 2.3. Structural alignment of Hp0100 and Sa2591. A. Structural alignment of 
Hp0100 (gray) and Sa2591 (cyan). B. Close-up of the alignment of the two AANH 
domains. C. Close-up of the alignment of the two P-loop domains. Rosetta [40] was used 
to generate the model of Hp0100 and I-TASSER [47] was used to generate the model of 
Sa2591.  
2.2 Results 
2.2.1 E. coli AspRS co-purifies with His6-Sa2591 
 E. coli aspartyl-tRNA synthetase (AspRS) co-purified with Hp0100 by nickel affinity 
chromatography after His6-Hp0100 was overexpressed in E. coli [38]. To begin to test our 
hypothesis that Sa2591 is a functional ortholog of Hp0100, we purified His6-Sa2591 and 
looked for co-purification of E. coli AspRS. The sa2591 gene was codon optimized for 
expression in E. coli and cloned into a vector with an N-terminal 6-histidine (His6) tag. A 
TEV protease cleavage site was added between the His6 tag and the start codon of 
Sa2591 so that the His6 tag could be removed for downstream experiments. His6-Sa2591 
Figure 2.3
Figure 2.3. Structural alignment of Hp0100 and Sa2591. A. Structural alignment of
Hp0100 (gray) and Sa2591 (cyan). B. Close-up of the alignment of the two AANH
domains. C. Close-up of the alignment of the two P-loop domains. Rosetta was used
to generate the model of Hp0100 and I-TASSER was used to generate the model of
Sa2591.
C. P-loop domain
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was overexpressed in E. coli and purified by nickel affinity chromatography and TEV 
protease was added to remove the His6 tag. The protein was further purified by size 
exclusion chromatography (SEC). A co-purifying protein was observed that is 
approximately the size of E. coli AspRS (~66 kDa) (Figure 2.4A, Sample 1). This 
observation suggested that the non-covalent interactions between these two proteins are 
strong. An aminoacylation assay with tRNAAsp was performed, which suggested that the 
66 kDa protein was E. coli AspRS (Figure 2.4B, Sample 1, black line). A later fraction of 
Sa2591 did not contain detectible levels of AspRS (Figure 2.4A, Sample 2) nor did it 
robustly aminoacylate tRNAAsp (Figure 2.4B, Sample 2, blue line). These results 
suggests that Sa2591 and E. coli AspRS form a complex in vivo and offered the first 
indication that Sa2591 might be a functional ortholog of Hp0100. 
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Figure 2.4. E. coli AspRS co-purifies with Sa2591. A.) A SDS-PAGE gel showing co-
purification of E. coli D-AspRS with Sa2591. Sa2591 was expressed in and purified from 
E. coli. The eluent from the Ni-NTA purification (load, lane 1) was further purified by SEC. 
Lanes 2 – 9 are the first 8 fractions collected from SEC. A co-purifying protein of 
approximately the molecular weight of E. coli D-AspRS (~66 kD, Sample 1, red box, lanes 
6 and 7) co-eluted with Sa2591 (Sample 1, green box, lanes 6 – 9). B.) Aminoacylation 
assays with tRNAAsp suggests that the 66 kD band in Sample 1 (lanes 6 and 7) is E. coli 
AspRS. Sample 2 (lanes 8 and 9) was also assayed as a comparison since the ~66 kDa 
band was not apparent in this sample.  
2.2.2 Sa2591 hydrolyzes ATP to ADP and Pi in the presence of post-
transcriptionally modified Asp-tRNAAsn or Glu-tRNAGln but not with tRNA 
transcripts. 
To further investigate if Sa2591 is a functional ortholog of Hp0100, Sa2591 was 
assayed for ATPase activity using an enzyme-coupled assay to specifically detect ADP 
production. This continuous, spectrophotometric assay provides initial rates for ATP 
hydrolysis to ADP and Pi [21]. ADP production is coupled to NADH oxidation via pyruvate 
kinase and lactate dehydrogenase with phosphoenolpyruvate and NADH as substrates, 
respectively. A decrease in absorbance at 340 nm indicates NADH oxidation and is 
directly correlated to ADP production (Figure 2.5A). Importantly, oxidation of NADH does 
not occur in the presence of either ATP or AMP (Figure 2.5B), demonstrating that this 
Figure 2.4
Figure 2.4. E. coli AspRS co-purifies with Sa2591. A.) A SDS-PAGE gel showing
co-purification of E. coli D-AspRS with Sa2591. Sa2591 was expressed in and
purified from E. coli. The eluant from the Ni-NTA purification (load) was further
purified by SEC. A co-purifying protein of approximately the molecular weight of E.
coli D-AspRS (-66 kD, Fraction 1, red box). co-eluted with Sa2591 (Fraction 1, green
box). B.) Aminoacylation assays with tRNAAsp confirmed that the 66 kD band in
Fraction 1 is E. coli AspRS. Fraction #2 was also assayed as a comparison since the
~66 kDa band was not apparent in this fraction.
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assay is specific for ADP. This assay was used to monitor Sa2591 for ADP production in 
the absence of tRNA and in the presence of misacylated tRNAs and correctly 
aminoacylated tRNAs from two different sources: tRNAs overexpressed in vivo versus 
those transcribed in vitro. The in vivo transcribed tRNAs were obtained by overexpressing 
the specific S. aureus tRNA isoacceptor in E. coli. These tRNAs possibly contain  critical 
post-transcriptional modifications on the tRNA however these samples are contaminated 
with total E. coli tRNA. (There is no good way of separating the overexpressed S. aureus 
tRNA from the E. coli tRNA during purification.) In vitro transcribed tRNA was also used 
because this allows us to be confident that only S. aureus tRNA is in the sample, however 
these tRNAs lack all post-transcriptional modifications and the importance of these 
modifications to Hp0100 and Sa2591 function remains untested. 
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Figure 2.5. Enzyme-coupled assay for ADP detection. A. Schematic of the ADP 
detection assay used with Sa2591 [21]. Pyruvate kinase (PK) uses ADP to convert 
phosphoenol pyruvate (PEP) to pyruvate. Lactate dehydrogenase (LDH) then uses NADH 
to reduce pyruvate to L-lactate. NADH absorbs light at 340 nm, but NAD+ does not. 
Consequently, the absorbance at 340 nm decreases as NADH is oxidized to NAD+ and 
this change in absorbance specifically correlates to ADP production. B. This assay is 
specific for ADP and insensitive to ATP and AMP. 
ATPase assays with misacylated S. aureus Asp-tRNAAsn and Glu-tRNAGln versus 
correctly aminoacylated S. aureus Asp-tRNAAsp and Glu-tRNAGlu from overexpressed, 
species-specific tRNA showed stimulation only in the presence of either misacylated 
tRNA (Figure 2.6A and B). Figure 2.6A shows the data for Sa2591 alone (black) and 
with either misacylated Asp-tRNAAsn (green) or Glu-tRNAGln (purple). The observed 
decrease in absorbance at 340 nm is observed for both assays with Asp-tRNAAsn and 
Glu-tRNAGln compared to Sa2591 alone, indicating that ATP is hydrolyzed to ADP and Pi, 
specifically in the presence of these misacylated tRNAs.  Figure 2.6B shows the data for 
Sa2591 with overexpressed tRNAs that have been correctly aminoacylated (Asp-tRNAAsp 
(blue) versus Glu-tRNAGlu (red)); these aminoacyl-tRNAs do not stimulate ATPase activity 
compared to Sa2591 alone (black). These results are consistent with those we’ve 
Figure 2.5
Figure 2.5. Enzyme-coupl d assay for D detection. A. Schematic of the ADP
detection assay used with Sa2591. Pyruvate kinase (PK) uses ADP to convert
phosphoenol pyruvate (PEP) to pyruvate. Lactate dehydrogenase (LDH) then use
NADH to reduce pyruvate to L-lactate. NADH absorbs light at 340 nm, but NAD+ does
not. Consequently, the absorbance at 340 nm decreases as NADH is oxidized to
NAD+ and this change in absorbance specifically correlates to ADP production. B.
Thi assay is specific for ADP and insensitive to ATP and AMP.
+ Pi
Abs = 340 nm
Sa2591 + aa-tRNA
A.
10
15
20
25
30
35
40
45
50
0 1 2 3 4 5
N
A
D
H
 ( µ
M
)
Time (min)
B. ATP and AMP controls
l = ATP 
n = AMP
 
 
37 
previously observed with Hp0100 [38]. In contrast, ATPase assays with misacylated Asp-
tRNAAsn and correctly aminoacylated Asp-tRNAAsp from in vitro transcribed tRNAs 
showed minimal stimulation by Asp-tRNAAsn (Figure 2.6C). The observation that Asp-
tRNAAsn from in vivo transcribed tRNA does stimulate the ATPase activity of Sa2591 and 
Asp-tRNAAsn from in vitro transcribed tRNA suggests that modifications on tRNAAsn are 
necessary for this activity. Additional experiments will need to be conducted to confirm 
this hypothesis. 
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Figure 2.6. Sa2591 enzyme-coupled assays to monitor ATPase activity. A. Assays 
of Sa2591 with misacylated tRNAs that were overexpressed in E. coli. Sa2591 alone 
(black), plus Asp-tRNAAsn (green) or Glu-tRNAGln (purple). ATP hydrolysis is stimulated in 
the presence of either misacylated tRNA as observed by the drop in absorbance at 340 
nm. B. Assays of Sa2591 in the presence of correctly aminoacylated tRNAs that were 
overexpressed in E. coli. Sa2591 alone (black), plus Asp-tRNAAsp (blue) or Glu-tRNAGlu 
(red). ATP hydrolysis is not stimulated compared to Sa2591 alone. C. Assay of Sa2591 
with in vitro transcribed tRNAs. Sa2591 alone (black), plus Asp-tRNAAsp (blue) or Asp-
tRNAAsn (green). ATP hydrolysis may be weakly stimulated by in vitro transcribed Asp-
tRNAAsn.
0
10
20
30
40
50
60
0 1 2 3 4 5
Sa2591 alone
Sa2591 + Asp-tRNAAsn
Sa2591 + Glu-tRNAGln
y = 50.885 - 0.79855x   R2= 0.991 
y = 49.368 - 1.2662x   R2= 0.99844 
y = 48.392 - 1.9765x   R2= 0.99255 
N
A
D
H
 (µ
M
)
Time (min)
0
10
20
30
40
50
60
0 1 2 3 4 5
Sa2591 alone
Sa2591 + Asp-tRNAAsp
Sa2591 + Glu-tRNAGlu
y = 47.772 - 1.1299x   R2= 0.98484 
y = 48.266 - 1.2587x   R2= 0.992 
y = 48.299 - 1.3083x   R2= 0.87273 
N
A
D
H
 (µ
M
)
Time (min)
0
10
20
30
40
50
60
0 1 2 3 4 5
Sa2591 alone
Sa2591 + Asp-tRNAAsp
Sa2591 + Asp-tRNAAsn
y = 46.66 - 1.2248x   R2= 0.99301 
y = 46.659 - 1.5018x   R2= 0.99694 
y = 46.659 - 1.8528x   R2= 0.99603 
N
A
D
H
 (µ
M
)
Time (min)
Figure	2.6	
A. ATPase activity with 
 misacylated tRNAs  
B. ATPase activity with 
 acylated tRNAs  
C. ATPase with in vitro 
transcribed tRNAs 
Sa2591 
Asp-tRNAAsp 
Asp-tRNAAsn 
Sa2591 
Asp-tRNAAsn 
Glu-tRNAGln 
Sa2591 
Asp-tRNAAsp 
Glu-tRNAGlu 
Figure 2.6. Sa2591 enzyme-coupled assays to monitor ATPase activity. A. Assay 
of Sa2591 with misacylated tRNAs that were overexpressed in E. coli. Sa2591 alone 
(black), plus Asp-tRNAAsn (blue) or Glu-tRNAGln (purple). ATP hydrolysis is stimulated 
in the presence of either misacylated tRNA as observed by the drop in absorbance at 
340 nm. B. Assay of Sa2591 in the presence of correctly aminoacylated tRNAs that 
were overexpressed in E. coli. Sa2591 alone (black), plus Asp-tRNAAsp (blue) or Glu-
tRNAGlu (red). ATP hydrolysis is not stimulated compared to Sa2591 alone. C. Assay 
of Sa2591 with in vitro transcribed tRNAs. Sa2591 alone (black), plus Asp-tRNAAsp 
(blue) or Asp-tRNAAsn (green). ATP hydrolysis is only weakly stimulated by in vitro 
transcribed Asp-tRNAAsn. 
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2.3 Discussion 
 Many microorganisms do not contain a full set of twenty aaRSs. When AsnRS or 
GlnRS is missing, these species must use an indirect pathway to aminoacylate tRNAAsn 
and tRNAGln [3, 4]. The intermediate products in this indirect tRNA aminoacylation 
pathway are misacylated tRNAs (Asp-tRNAAsn and/or Glu-tRNAGln). Microorgansisms that 
use this pathway must prevent these misacylated tRNAs from entering the ribosome 
where they could cause translational errors that could be detrimental to the cell [2]. One 
way that cells prevent Asp-tRNAAsn from entering the ribosome is through the formation 
of a ribonucleoprotein complex, called the Asn-transamidosome. When our lab 
discovered Hp0100, we hypothesized that this protein may drive Asn-transamidosome 
formation in H. pylori and, in fact, it is required for formation of a stable, tRNA-independent 
Asn-transamidosome (Figure 1.7) [34]. Hp0100 increases the transamidation rates of 
GatCAB with both Asp-tRNAAsn and Glu-tRNAGln as substrates. Hp0100 is also an 
ATPase with two distinct active sites that are stimulated by two different misacylated 
tRNAs [34, 38]. To our knowledge, this is the first ATPase to contain two distinct active 
sites that are activated by two different substrates.  
 We recently discovered a truncated ortholog of Hp0100 in S. aureus, called Sa2591. 
Because of their sequence and structural similarities we hypothesized that Sa2591 is a 
functional ortholog of Hp0100. When we were first studying Sa2591, we observed that a 
protein about the size of E. coli AspRS (~66 kDa) co-purified with Sa2591 (Figure 2.4A) 
through Ni2+ and size exclusion chromatography. An aminoacylation assay was 
performed with the co-purifying protein and the results are consistent with it being E. coli 
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AspRS (Figure 2.4B). This was our first indication that Sa2591 is a functional ortholog of 
Hp0100.  
Sa2591 was assayed for ATPase activity using a continuous, spectrophotometric, 
enzyme-coupled assay (Figure 2.5) [21]. The results show that Sa2591 hydrolyzes ATP 
to ADP and Pi only in the presence of misacylated tRNAs (Figure 2.6A) and not in the 
presence of correctly aminoacylated tRNAs (Figure 2.6B) when tRNAs that were 
overexpressed in E. coli were used. Sa2591 ATPase activity was only slightly stimulated 
in the presence of Asp-tRNAAsn when the tRNA was in vitro transcribed and therefore 
lacking all post-transcriptional modifications (Figure 2.6C). These results suggest that 
tRNA modifications are crucial for the ATPase activity of Sa2591 and that Sa2591 seems 
to be a functional ortholog of Hp0100 under conditions that most closely recapitulate 
those encountered in vivo (namely, with modified tRNA substrates). 
 Working with Hp0100 proved intractable and thus we chose to characterize Sa2591, 
building on and completing Dr. Gayathri Silva’s work with Hp0100 [38]. The results 
presented in this chapter are just the beginning of the characterization of Sa2591. Sa2591 
contains a putative metal binding site and the characterization of its metal binding has 
been completed and is the focus of Chapter 3. We are currently making analogous 
mutations in the AANH and P-loop domain of Sa2591 as those that were inserted into 
Hp0100 [38]. Analyses of these mutant variants are expected to demonstrate that the two 
ATPase active sites of Sa2591 can be functionally separated, results that were never 
published by Dr. Silva because of challenges working with Hp0100 in vitro. Studies to 
characterize the effect of Sa2591 on the transamidation activity of GatCAB are also 
currently underway and are being conducted by Udumbara Rathnayake. It is also 
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assumed that Sa2591 will increase the transamidation rates of Asp-tRNAAsn to Asn-
tRNAAsn and Glu-tRNAGln to Gln-tRNAGln by GatCAB.  Importantly, given the results 
presented here, we will now also more deeply assess the impact of post-transcriptional 
modifications on the different roles played by Sa2591.  
 Future studies should also confirm that Sa2591 is necessary to form an S. aureus 
transamidosome complex similar to Hp0100’s central role in the H. pylori Asn-
transamidosome [34]. However, we cannot predict if the S. aureus transamidosome will 
be exactly analogous to the H. pylori tRNA-independent transamidosomes because 
Sa2591 is ~1/3 shorter than Hp0100 (Figure 2.3A). The absence of this C-terminal 
extension could change the requirements for formation of an S. aureus transamidosome. 
For example, the S. aureus transamidosome may or may not need tRNA for stable 
complex formation. We cannot rule out that the extra domain of Hp0100 may be the 
reason that the H. pylori Asn-transamidosome is tRNA-independent. It is interesting that 
full-length orthologs of Hp0100 are only found in the e-proteobacteria and that the H. pylori 
Asn-transamidosome is the only transamidosome known so far that is tRNA-independent 
[24, 34]. Nevertheless, it is likely that the S. aureus transamidosome will prove to be 
tRNA-independent as well. However, given the close functional similarities between 
Hp0100 and Sa2591, we can be certain that Sa2591 is involved in indirect tRNA 
aminoacylation in MRSA.  
2.4 Materials and Methods 
2.4.1 Materials 
 Primers and diethyl pyrocarbonate (DEPC) were purchased from Sigma-Aldrich (St. 
Louis, MO). Restriction enzymes were purchased from New England Biolabs (NEB, 
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Ipswich, MA). Plasmids for cloning were purified using the E.Z.N.A.® Plasmid Mini Kit II 
from Omega Bio-Tek (Norcross, GA). Ethylenediaminetetraacetic acid (EDTA) is from 
Fisher Scientific (Hampton, NH). Ampicillin, isopropyl b-D-thiogalactopyranoside (IPTG), 
phenylmethanesulfonyl fluoride (PMSF), lysozyme, tris(hydroxymethyl) aminomethane 
(tris), and boric acid were purchased from GoldBio Biotechnology, Inc., (St. Louis, MO). 
All plasmid sequences were confirmed by the Sequencing Lab at the Applied Genomics 
Technology Center at Wayne State University School of Medicine.  
2.4.2 Cloning of Sa2591 
 The sa2591 gene was codon optimized for expression in E. coli and chemically 
synthesized for insertion into the pUC57 vector by GenScript (GenScript Biotech Corp., 
Piscataway, NJ) with BamHI and SalI sites appended onto the 5’ and 3’ ends of the gene, 
respectively. The gene was subsequently cloned into the EcoRV site of pUC57. The 
sa2591 gene was then sub-cloned into the pQE80L vector using its BamHI and SalI 
restrictions sites (pWNW002). This vector appends a His6 tag onto the N-terminus of the 
encoded protein. A TEV protease cleavage site was inserted into the open-reading frame 
between the His6 tag and the start codon to allow for removal of the His6 tag for later 
studies where the tag would cause interference (pWNW003). To add the TEV protease 
cleavage site, BamHI restriction endonuclease was used to digest pWNW002, where it 
would cut the plasmid once between the His6 tag and the start codon of the sa2591 gene. 
Calf Intestinal Alkaline Phosphatase (CIP, NEB, Ipswich, MA) was added to remove the 
phosphates from the 5’- and 3’-ends of the pWNW002 DNA. The sequences of the 
primers used to add the TEV protease cleavage site are: forward primer UD015:  
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5’-GATCCGAAAACCTGTACTTCCAAGGCGGTACCG-3’ and reverse primer UD016: 5’-
GATCCGGTACCGCCTTGGAAGTACAGGTTTTCG-3’. These primers contain the 
coding sequence for the TEV protease cleavage site and have complementary overhangs 
to the BamHI-digested pWNW002. They were mixed together in an equal molar ratio (0.2 
pmoles each). This primer mix was then added to BamHI-digest pWNW002 DNA in a 
ratio of 5:1 (1 pmole primer mix:0.2 pmoles vector). A T4 DNA ligase reaction was 
performed using enzyme and reaction buffer provided by NEB (Ipswich, MA). The ligation 
reaction was transformed into E. coli DH5a chemically competent cells and was plated 
on Luria Bertani (LB) plates supplemented with 0.5% glucose and 100 µg/mL ampicillin 
to allow for selection of colonies. Plasmid was purified from colonies and the sequence 
was confirmed resulting in pWNW003, which was used for expression of Sa2591.  
2.4.3 Overexpression and purification of Sa2591 
Sa2591 was overexpressed in E. coli DH5a by inoculating a 0.5 L culture of LB 
medium supplemented with 0.5% glucose and 100 µg/mL ampicillin with a 5 mL overnight 
culture grown in the same medium. The culture was incubated at 37 °C, 225 rpm, until 
the optical density (OD) at 600 nm reached 0.4-0.6. Protein expression was induced with 
1 mM ITPG. The culture was grown at 19 °C, 225 rpm, for 14-16 hours. Cells were 
harvested by centrifugation. The cell pellet was suspended in 5 mL of lysis buffer (50 mM 
NaH2PO4, pH 7.4, 1 M NaCl, 10 mM imidazole, 1 mM b-mercaptoethanol) and cells were 
lysed using 2 mg/mL lysozyme. Aliquots of a saturated solution of PMSF (75 µL) were 
added every 15 min to reduce proteolysis. The suspension was incubated on ice for 30 
min and then sonication was performed 6 times using a Misonix Microson™ Ultrasonic 
Cell Disruptor set at power level 4 for 10 seconds, with 50 second rest cycles on ice in 
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between each pulse. Cell debris was removed by centrifugation at 14,000 rpm for 30 min 
at 4 °C. The cleared lysate was filtered through a 0.8 um filter and then a 0.2 um filter 
(Acrodisc® syringe filters with Supor® membrane, Pall Corporation, Port Washington, 
NY) before purification on a HiTrap Chelating High Performance (HP) affinity column (GE 
Healthcare Life Sciences, Pittsburg, PA). His6-Sa2591 was purified essentially according 
to the manufacturer’s protocol. TEV protease was added to the eluent in a ratio of 1 mg 
TEV to ~5 mg Sa2591. The cleavage reaction was diluted to 15 mL using dialysis buffer 
A (50 mM NaH2PO4, pH 7.4, 300 mM NaCl, 0.5 mM EDTA, 10 mM b-mercaptoethanol) 
and placed inside dialysis tubing (6-8 kDa MWCO, Spectrum Labs, Irving, TX). The 
reaction was dialyzed in 2 L dialysis buffer A at 4 °C overnight to remove the His6 tag. 
The dialysis buffer was exchanged to 2 L dialysis buffer B (dialysis buffer A with 1 mM b-
mercaptoethanol) and dialyzed for 1-2 hours. The His6-tagged TEV protease was 
removed by passing the reaction through a HiTrap Chelating HP affinity column. The flow 
through containing Sa2591 was concentrated using an Amicon 10 kDa MWCO tube (EMD 
Millipore, Burlington, MA). The protein concentration was calculated by UV-Vis 
spectroscopy at 280 nm, using Beer’s law with an extinction coefficient of 27,850 cm-1 M-
1 (determined by the ExPASy ProtParam tool within the Proteomics server [74]). Sa2591 
was stored in 50% glycerol at -20 °C and used for assays within ~1 week of purification. 
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2.4.4 Overexpression and purification of S. aureus ND-GluRS and ND-AspRS 
 The S. aureus gltX (ND-GluRS) gene was codon optimized for expression in E. coli 
and chemically synthesized into the pUC57 vector by GenScript (GenScript Biotech 
Corp., Piscataway, NJ). BamHI and KpnI sites were engineered onto the 5’ and 3’ ends 
of the gene, respectively, and the gene was cloned into the EcoRV site of pUC57. The 
gltX gene was then sub-cloned into the pQE80L vector using its BamHI and KpnI 
restrictions sites (pWNW009). This vector appends a 6-Histidine (His6) tag onto the N-
terminus of the encoded protein. ND-GluRS was overexpressed in E. coli DH5a by 
inoculating a 1 L culture of LB medium supplemented with 0.5% glucose and 100 µg/mL 
ampicillin with a 10 mL overnight culture grown in the same medium. The culture was 
incubated at 37 °C, 225 rpm, until the OD at 600 nm reached 0.8-1.0. Protein expression 
was induced with 1 mM ITPG. The culture was grown at 19 °C, 225 rpm for 4 hours. Cells 
were harvested by centrifugation. The cell pellet was lysed following the protocol 
described above for Sa2591 in the same lysis buffer except with the addition of 300 mM 
NaCl. The cleared lysate was added to a polyprep column that contained ~2 mL of High-
Density Cobalt Agarose Beads (GoldBio Biotechnology, Inc., St. Louis, MO) and the 
lysate was incubated with the resin by rotating at 4 °C for 1 hour. His6-ND-GluRS was 
purified essentially according to the manufacturer’s protocol. The eluent was added to 
dialysis tubing (6-8 kDa MWCO, Spectrum Labs, Irving, TX) and dialyzed against 2 L 
dialysis buffer (50 mM NaH2PO4, pH 7.4, 300 mM NaCl) at 4 °C for 1-2 hours and then 
against fresh dialysis buffer overnight. ND-GluRS was concentrated using an Amicon 30 
kDa MWCO tube (EMD Millipore, Burlington, MA). The protein concentration was 
calculated by UV-Vis spectroscopy at 280 nm using an extinction coefficient of 69,790 
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cm-1 M-1 [74]. ND-GluRS was stored in 50% glycerol at -20 °C and used within ~1-2 
months of purification. 
 The S. aureus ND-AspRS plasmid was kindly provided by Kelly Sheppard. The protein 
was overexpressed in E. coli BL21(DE3) RIL and purified as previously described [16]. 
ND-AspRS was concentrated using an Amicon 30 kDa MWCO tube (EMD Millipore, 
Burlington, MA). The protein concentration was calculated by UV-Vis spectroscopy at 280 
nm using the extinction coefficient of 48,820 cm-1 M-1 [74]. ND-AspRS was stored in 50% 
glycerol at -20 °C and used within ~1-2 months of purification. 
2.4.5 In vivo expression of S. aureus tRNAAsn, tRNAAsp, tRNAGln, and tRNAGlu 
 S. aureus tRNAs were overexpressed in the E. coli strain MV1184, purified, folded 
and quantified by aminoacylation assay as previously described [23]. This approach 
provides tRNA that is highly enriched in the overexpressed isoacceptor but also contains 
total E. coli tRNA. 
2.4.6 In vitro transcription of S. aureus tRNAAsn and tRNAAsp 
 The S. aureus tRNAAsp plasmid was kindly provided by Kelly Sheppard, and tRNAAsn 
plasmid was chemically synthesized into the pUC57 vector by GenScript (GenScript 
Biotech Corp., Piscataway, NJ). The 2 tRNA plasmids contain a T7 RNA polymerase 
promoter sequence and a BstNI site at the 5’ and 3’ ends of the tRNA DNA sequence, 
respectively. This sequence allows for run-off transcription of the BstNI-digested plasmid 
DNA that results in unmodified tRNA with the correct 5’ and 3’ termini, specifically in tRNA 
that begin with a 5’-guanine (G) base [75]. However, for the tRNAAsn plasmid, a 
hammerhead ribozyme sequence was added between the T7 RNA polymerase promoter 
sequence and the start of the tRNA DNA sequence because its tRNA sequence starts 
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with a uracil (U) base [76]. This modification was performed because T7 RNA polymerase 
leaves the last G base of its promoter sequence as the starting base of the RNA transcript 
[76]. After transcription, a hammerhead ribozyme reaction was performed so that the 
resulting tRNAAsn transcript begins with its native 5’-U base. S. aureus tRNAAsp starts with 
a 5’-G base, so the hammerhead ribozyme was not needed.  
 All buffers used for plasmid purifications, BstNI digestions, transcriptions, and 
hammerhead ribozyme reactions were made in DEPC-treated water unless buffers were 
provided by the relevant companies. Transcription reactions were performed as 
previously described [75], except 5 µM T7 RNA polymerase was used and reactions were 
performed at 30 °C for 2 hours. Transcription of tRNAAsn was performed using 30 mM 
MgCl2, whereas only 1 mM MgCl2 was used for transcription of tRNAAsp. The 
hammerhead ribozyme reaction for tRNAAsn transcripts was performed as previously 
described [76], expect reactions were incubated for 2 hours. For both tRNA transcripts 
after phenol/chloroform extraction and isopropanol precipitations, the tRNAs were purified 
using a 9 M urea, 8% acrylamide (Bio-Rad Laboratories, Inc., Hercules, CA) mini gel in 
TBE running buffer (89 mM tris, 89 mM boric acid, 2 mM EDTA, pH 8.0) at 300 volts for 
30 minutes. The tRNA transcript band was excised from the gel and pushed through a 3 
mL syringe to crush the gel into pieces. The crushed gel pieces and crush and soak buffer 
(0.5 M ammonium acetate, 1 mM EDTA, pH 5.2) were added to a polyprep column and 
incubated at 37 °C overnight while rotating. The buffer suspension was eluted from the 
polyprep column and the eluent was isopropanol precipitated for 1 hour at -20 °C. The 
tRNA transcripts were centrifuged at 10,000 x g for 20 min and the pellet was dried and 
suspended in water.  
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2.4.7 Size exclusion chromatography suggests that E. coli AspRS co-purifies with 
Sa2591 
 Immediately following the purification of Sa2591 from TEV protease by nickel affinity 
chromatography, Sa2591 was concentrated to ~2 mL using an Amicon 10 kDa MWCO 
centrifuge tube (EMD Millipore, Burlington, MA). This was filtered using a 0.2 um syringe 
filter and injected onto a FCV-20AH2 Shimadzu High Pressure Switching Valve unit 
(Shimadzu, Kyoto, Kyoto Prefecture, Japan) connected with a 2 mL loop. The column 
was packed with Sephacryl™ S-300 High Resolution size exclusion chromatography 
resin (GE Healthcare Bio-Sciences, Uppsala, Sweden). The column was connected to a 
LC-20AD Shimadzu Liquid Chromatography solvent delivery unit. Size exclusion 
chromatography was performed at 4 °C using Shimadzu LC Solutions software and the 
settings were as follows: Pump B was set at 0% (100% Pump A), 0.5 mL/min flowrate, 
2000 µL injection volume, 360 min data acquisition, isocratic flow, and maximum pressure 
was set at 150 psi. SEC buffer was used for Pump A (50 mM NaH2PO4, pH 7.4, 300 mM 
NaCl). Fractions (5 mL) were collected beginning at 120 min, and were collected until 300 
minutes. Fractions were analyzed by 12% SDS-PAGE. 
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2.4.8 Aminoacylation assays of tRNAs 
 All tRNAs was refolded in the presence of 2 mM MgCl2 and aminoacylation assays 
were performed as previously described [13]. For aminoacylation assays with tRNAAsp to 
test if E. coli AspRS was co-purifying with Sa2591, 6.5 µg of total protein from the fractions 
collected from SEC were used to initiate the assay. For aminoacylation assays to 
misacylate S. aureus tRNAAsn and tRNAGln or to correctly aminoacylate S. aureus tRNAAsp 
and tRNAGlu, 1 µM S. aureus ND-AspRS and ND-GluRS were used, respectively. Stocks 
of Asp-tRNAAsn, Glu-tRNAGln, Asp-tRNAAsp, and Glu-tRNAGlu (100 µM) were prepared in 
parallel to assays that contained radiolabeled amino acids. 
2.4.9 Enzyme-coupled ATPase assay for ADP detection 
 ATPase assays were performed as previously described [21]. This assay monitors 
ATP hydrolysis to ADP + Pi specifically by coupling ADP production to the oxidation of 
NADH to NAD+. The decrease in NADH can be monitored over time at 340 nm and is 
directly correlated to the production of ADP. Assays were done using 10 µM misacylated 
or correctly aminoacylated tRNA. All assays were conducted in triplicate from different 
enzyme purifications (biological replicates). Assays were performed in a Beckman Coulter 
DU800 spectrophotometer, recording absorbance readings at 340 nm every 2 seconds 
for a total of 5.5 minutes. Assays were initiated with the addition of 200 nM Sa2591 only 
after the absorbance at 340 nm had stabilized. Absorbance was converted to NADH 
concentration using 6,220 M-1 cm-1 as the extinction coefficient (Sigma-Aldrich, St. Louis, 
MO) [77]. Data was averaged and plotted as NADH concentration versus time with 
standard deviation for each time point represented as error bars on the plot. 
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CHAPTER 3: QUEH, A MISACYLATED-TRNA-DEPENDENT ATPASE AND 
PROBABLE EPOXYQUEUOSINE REDUCTASE, IS A METALLOPROTIEN 
3.1 Introduction 
 Our lab discovered that Hp0100 and its orthologs are involved in indirect tRNA 
aminoacylation. Hp0100 is required for tRNA-independent Asn-transamidosome complex 
formation in H. pylori and it accelerates the transamidation of Asp-tRNAAsn to Asn-tRNAAsn 
by GatCAB [34]. In Chapter 2, a truncated version of Hp0100 from S. aureus, Sa2591, 
was characterized and results suggest that it is a functional ortholog of Hp0100. These 
proteins, all members of the DUF208 superfamily, have two distinct ATPase active sites, 
an AANH-like domain and a P-loop, that are activated by misacylated tRNAs. We have 
unpublished data that suggest that ATP hydrolysis is connected to their ability to activate 
GatCAB. While full-length orthologs of Hp0100 are unique to the e-proteobacteria, 
truncated versions, comprising approximately 2/3 of the primary sequence are found in 
many different bacteria (Figure 3.1). Figure 3.1 shows alignments of the primary 
sequence of DUF208 from 7 different bacterial species. Remarkably, comparative 
genomics identified the DUF208 protein family as epoxyqueuosine reductases, 
responsible for catalyzing the final step in queuosine biosynthesis [48].  
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Figure 3.1. Sequence alignments of DUF 208 proteins from different bacterial 
species. The sequence alignments from 7 different bacteria are shown. Hp, H. pylori; 
Tm, T. maritima; De, D. ethenogenes; Bp, B. pertussis; Sp, S. pyogenes; Se, S. 
epidermidis; and Sa, S. aureus. Rigorously conserved residues are labeled with an 
asterisk; highly conserved residues are marked with a colon; and loosely conserved 
residues are marked with a period. 
Hp      --------------------------------------MLIHICCSVDNLYFLKKAKEAF
Tm      -----------------------------------MGTVLIHVCCAPDLLTTIF------
De      ----------------------------------MAPKLLLHGCCAHCTAYSFKYWQE--
Bp      ---------------------MSQLVRPTLELPAGRRKVLLHSCCAPCSGEVMEAMTA--
Sp MIDLQEILANMNPNQKINYDRVMQQMAKVWEKESVRPSILMHVCCAPCSTYTLEYLTQ--
Se      MIEANQILAKM-KNQKINYDKVLRKIISQWERDGERPKILLHSCCAPCSTYTLEFLTQ--
Sa      MINAEPIISKM-KNQKINYDKVLKKLIGQWEREAIRPKILLHSCCAPCSTYTLEFLTQ--
:*:* **:      :      
Hp      AGEKIVGFFYNPNIHPYSEYLLRLEDVKRTCEMLG------IELLEGDYEL---EKFLDK
Tm      HVRDAEFFFYNPNIQPLSEYEKRREAVDKVANHFS------LNVRYGEYSTEEIRKWYTA
De      QGFAVSVYWYNPNIHPFMEHQSRLEAMRKLSAEMGFE-----LITEPSYHM---AEYFKN
Bp      SGIDYAIYFYNPNIHPVKEYEIRKNENIRFAEE------HGIEFIDADYDM---DNWFER
Sp -FADITVYFANSNIHPKDEYHRRAYVTQQFVSEFNAKTGNTVQFLEADYVP---NEYVRQ
Se      -YADIAIYFANPNIHPKSEYLRRAKVQEQFVNDFNNKTGASVKYIEAEYEP---HKFMKM
Sa      -YADIAIYFANSNIHPKNEYLRRAKVQEQFVEDFNRKTGANVKYIEAPYEP---HKFVKM
:: * **:*  *:  *     :                   *      ::  
Hp      A--KGKELLGEKSERCFECFDLRLEASALKAFELGEEKFTTTLLTSPKKDPNQLIAKGQS
Tm      V--KDYKDLGEGSKRCERCISFLLERTAQEARKRGHESFSTTLLASPRKNLPMIENIGKT
De      VS-------ANVDGRCRICFDMRLGQTAAYAAGHGYEYFSSSLFISPHQKHQDAVCSAEA
Bp      V--KGMENEPERGIRCTACFDMRFERTALYAHEHGFDTITSSLGISRWKDMNQINGCGER
Sp V--RGLEEEPEGGDRCRVCFDYRLDKTAQKAVELGFDYFASALTISPHKNSQTINDVGID
Se      AKDKGLTEEPEGGLRCTACFEMRLEIVAKAALEHGYDYFGSAITLSPKKNAQLINELGMD
Sa      VKDKELADEKEGGLRCTACFEMRLDIVAKAAVEHGYDYFGSAITLSPKKNAQLINELGMD
.         : . **  *:.  :   *  *   * : : :::  *  :.       .  
Hp      IAQRH-NLEFVVFRNDNFEHFKSELDLNLQALARENELYRQNYCGCQFALKIQKESQNRS
Tm      IEEKY-GVKFFFKNFRKGGAYQ-----EGVRLSKELGIYRQNYCGCVFSLLERREKHAEI
De      LAK-ETGVRFAYADLRK--RYS-----DSRHITKPLDLYRQQYCGCVYSEYERFGKPNS-
Bp      AAARYDDLVYWTYNWRKGGGSQ-----RMIEISKRENFYQQEYCGCVYSLRDTNRHRRAQ
Sp VQKVY-TTKYLPSDFKKNNGYR-----RSVEMCEEYDIYRQCYCGCVYAAKMQGIDLVQV
Se      VQNIY-NVKYLPSDFKKNKGYE-----RSIEMCNDYNIFRQCYCGCVFAAMKQGIDFKQI
Sa      VQKIY-DVNYLPSDFKKSKGYE-----RSIEMCNDYNIFRQCYCGCVFAAMQQGIDFKTV
:      :              : .   :::* **** ::          
Hp      PFELYSPLKRQILPASIEERTQVFRTLDMAKKDANKPFLAQKTIATYRLLNGGVWLSKNS
Tm      SRK------RGHM-----------------------------------------------
De      --PA--------------------------------------------------------
Bp      GRER-------------IHLGVKFYGVEEKL-----------------------------
Sp KKDAKAFMADKDLDNDFTHIRFSYRGDEM-------------------------------
Se      NKDAQAFLQQF-------------------------------------------------
Sa      NKEAKAFLEQYPD-----------------------------------------------
Hp      NPLNCCILARSKSKAKVRINDLRWVFSQRLSVLVGYSQRDETLFLTLEGLNTLMAKNYDN
Tm      ------------------------------------------------------------
De      ------------------------------------------------------------
Bp      ------------------------------------------------------------
Sp ------------------------------------------------------------
Se      ------------------------------------------------------------
Sa      ------------------------------------------------------------
Hp      LKELNLNPLNYEEELSLRALVSGSESINPIIVLEERTEKTLFVEIKSVFQEEKVFYLL
Tm      ----------------------------------------------------------
De      ----------------------------------------------------------
Bp      ----------------------------------------------------------
Sp ----------------------------------------------------------
Se      ----------------------------------------------------------
Sa      ----------------------------------------------------------
 
 
52 
Queuosine (Q) is a post-transcriptionally modified guanosine base found at the first 
position in the anticodons of tRNAAsp, tRNAAsn, tRNAHis, and tRNATyr [49]. The last three 
steps of queuosine biosynthesis occur on the tRNA and utilize 3 enzymes: tRNA-guanine 
tranglycosylase (TGT), QueA, and QueG (Figure 1.8) [50-52]. Several bacteria have TGT 
and QueA, and contain queuosine in there tRNA, but lack QueG. This observation led de 
Crécy-Lagard and coworkers to identify the DUF208 family of proteins as non-orthologous 
replacements to QueG [48]. Proteins from this group, including Hp0100 and Sa2591, 
were able to restore queuosine biosynthesis in a ∆QueG E. coli strain by 
complementation. These authors proposed naming the DUF208 proteins QueH [48]. 
Consequently, from here on, Sa2591 will be called QueH.  
QueG contains a redox chain of two [4Fe-4S] iron-sulfur clusters and uses cobalamin 
to reduce epoxyqueuosine to queuosine [53, 54]. However, de Crécy-Lagard and co-
workers did not find any cobalamin associated with QueH [48]. In our model structure of 
S. aureus QueH (Sa2591), there are several, clustered, conserved cysteine residues, 
including a CXXC motif in the P-loop ATPase domain (Figure 3.2) [47]. This chapter 
focuses on our analysis of the metal-binding capacity of S. aureus QueH. Using different 
spectroscopy techniques, we have demonstrated that S. aureus QueH binds at least two 
Fe(II) atoms, although these irons are not in an Fe-S cluster. We hypothesized that S. 
aureus QueH uses its Fe2+-binding sites to reduce epoxyqueuosine to queuosine and we 
conducted a number of assays in an attempt to observe this activity. QueH has proven to 
be a complex protein that is involved in many different aspects of tRNA biology. 
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Figure 3.2. Model of S. aureus QueH (Sa2591) showing conserved cysteine 
residues. A close-up of the five conserved cysteines is shown. Residues C129 and C132 
are in the CXXC motif in the P-loop domain (blue). In constructing this model, I-TASSER 
connected C129 and C213 in a disulfide bond; however, their actual oxidation states are 
unknown [47]. 
3.2 Results 
3.2.1 QueH has an Fe(II) binding site 
The model structure of QueH shows a putative metal binding site with 5 conserved 
cysteines clustered together (Figure 3.2) [47]. To gain preliminary evidence of metal 
binding, several different monovalent, divalent, and trivalent metal ions were 
spectroscopically analyzed with QueH by performing UV-Vis wavelength scans from 250 
– 700 nm. In each experiment, QueH and the relevant metal solution were scanned alone 
and together. Difference spectra, subtracting the metal alone and QueH alone spectra 
from the combined spectrum, were used to visualize potential metal-binding effects. 
Figure 3.3 shows this series of spectra for 4 different metals (panels A-D). Fe(II) was the 
Figure	3.1	
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Figure 3.1. M del of S. aureus Que (Sa2591) showing conserved cyst ine 
residues. A close-up of the five conserved cysteine residues is shown. Residues 
C129 and C132 are in the CXXC motif in the P-loop domain (blue). In constructing 
this model, I-TASSER connected C129 and C213 in a disulfide bond; however, their 
actual oxidation states are unknown. 
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only metal that had any effect, (Figure 3.3A, inset); the  shift in the spectrum around 360 
nm suggests Fe(II) binding to QueH.  
Figure 3.3. UV-Vis wavelength scan of QueH with different divalent and trivalent 
metals. A scan was taken of 20 µM QueH alone (red line), 0.5 mM metal alone (blue 
line), and QueH mixed with metal (black line). The inset represents the difference in the 
spectra of QueH mixed with metal and the two spectra of QueH alone and metal alone. 
A. FeCl2, B. FeCl3, C. NiSO4, D. ZnCl2.  
3.2.2 QueH binds two Fe(II) ions with low micromolar Kd values 
 To further investigate interactions between QueH and Fe(II), we collaborated with Dr. 
Timothy Stemmler and Brianne Lewis at the Wayne State University School of 
Pharmaceutical Sciences. We utilized an Fe(II) competition binding assay that relies on 
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Figure 3.2. UV-Vis wavelength scan of QueH with different divalent and trivalent 
metals. A scan was taken of 20 µM QueH alone (red line), 0.5 mM metal alone (blue 
line), and QueH mixed with metal (black line). The inset represents the difference in 
the spectra of QueH mixed with metal and the two spectra of QueH alone and metal 
alone. A. FeCl2, B. FeCl3, C. NiSO4, D. ZnCl2.  
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the metal chelator, mag-fura-2 [78]. Mag-fura-2 binds Fe(II) in a 1:1 complex with a Kd of 
2.0 µM (Figure 3.4) [78]. It has a characteristic UV absorbance at 366 nm in its apo state, 
which shifts to 325 nm upon Fe(II) binding. This competition assay was used with QueH 
to determine the stoichiometry of Fe(II) binding and to estimate the Kd of this interaction 
(Figure 3.4). Figure 3.4B shows results of a representative assay with QueH and mag-
fura-2 in a 1:1 molar ratio; Fe(II) was titrated in from 0 to ~40 µM. A progressive decrease 
in absorbance at 366 nm with a concomitant increase in absorbance at 325 nm was 
observed, indicating Fe(II) binding to QueH. Several competition assays were conducted, 
varying the ratio of QueH:mag-fura-2.  
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Figure 3.4. QueH:Fe(II) competition binding assay using mag-fura-2. A. Structure of 
mag-fura-2 and the mag-fura-2•Fe(II) complex, which has a Kd of 2.0 µM [78]. B. Fe(II) 
competition binding assay. Mag-fura-2 and QueH are in a 1:1 molar ratio. The black line 
indicates the spectrum of QueH alone and the dark blue line represents QueH with 
mag-fura-2. Mag-fura-2 has a maximum absorbance at 366 nm that shifts to 325 nm 
upon Fe(II) binding. Fe(NH4)2(SO4)2 was titrated into the solution from 0 to 40 µM. Fe(II) 
binding to QueH resulted in a decrease in absorbance at 366 nm and an increase in 
absorbance at 325 nm. Competition assays were conducted in an anaerobic chamber in 
Dr. Stemmler’s lab with Brianne Lewis. 
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Figure 3.3. QueH:Fe(II) competition binding a say using Mag-fura-2. A. Structure 
of mag-fura-2 and mag-fura-2 bound to Fe(II), w ich h s a Kd of 2.0 µM. . (II) 
competition binding assay. Mag-fura-2 and QueH are in a 1:1 molar ratio. The black 
line is Qu H alone and the dark blue line is QueH with mag-fu a-2. Mag-fura-2 as a 
maximum absorb nce at 366 nm and shifts to 25 nm upon Fe(II) bi ding. 
Fe(NH4)2(SO4)2 was titrated into the solution from 0 to 40 µM. Fe(II) binding to Qu H 
resulted in a decrease i  bsorbance at 366 nm and an incre se in absorbance at 
325 nm. Competition assays were conduct d in an anaerobic chamber in Dr. 
Stem ler’s lab with Brianne Lewis. 
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Using the program DynaFit (BioKin Ltd., Watertown, MS), the absorption decay at 366 
nm was used to determine stoichiometry of Fe(II) binding to QueH and to estimate Kd. 
The data from these assays were fit to models of a 1:1, 1:2, and 1:3 QueH:Fe(II) binding 
ratio (equations 1 – 3, respectively).  
QeuH-Fe(II)  QueH + Fe(II)                  (eq. 1) 
QueH-Fe(II)-Fe(II)  QueH + Fe(II) + Fe(II)            (eq. 2) 
QueH-Fe(II)-Fe(II)-Fe(II)  QueH + Fe(II) + Fe(II) + Fe(II)       (eq. 3) 
In all cases, results were best fit to a 1:2 binding model, eq. 2 (Figure 3.5). The 
estimated Kd values for each binding event are 4.5 ± 1.0 µM and 11.2 ± 3.7 µM. Figure 
3.5 shows the representative fits for a 1:2 QueH:Fe(II) binding model that was generated 
from absorption decay at 366 nm from data collected from competition assays with 1:2 
QueH:mag-fura-2 (blue line), 1:1 QueH:mag-fura-2 (black line), 2:1 QueH:mag-fura-2 
(green line). These results show that all 3 ratios of QueH:mag-fura-2 best fit a 1:2 
QueH:Fe(II) binding model.  
Kd1 
Kd2 
Kd3 
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Figure 3.5. QueH binds two Fe(II) ions. The absorption decay at 366 nm was used to 
fit for a 1:2 QueH:Fe(II) binding model using the program DYNAFIT from 3 different 
competition assays with varying ratios of QueH:mag-fura-2. n = 1:2 QueH:mag-fura-2; l 
= 1:1 QueH:mag-fura2; u = 2:1 QueH:mag-fura-2. Individual data points represent raw 
assay data. The lines represent the data fits used to obtain Kd values for both Fe(II) 
binding events (4.5 µM and 11.2 µM).  
3.2.3 X-Ray absorption spectroscopy confirms QueH binds Fe(II) 
X-Ray absorption spectroscopy (XAS) data were collected at the Stanford 
Synchrotron Radiation Lightsource at the SLAC National Accelerator Laboratory [79]. 
Duplicate samples of QueH were loaded with 2 equivalents of Fe(II) under anaerobic 
conditions for full Fe-XAS analysis. The X-Ray absorption near edge structure (XANES) 
spectra are shown in Figure 3.6. Based on the edge energy, each QueH sample contains 
a high spin ferrous species. The inset in Figure 3.6 shows the pre-edge feature between 
7110 – 7115 eV for both samples. This region is consistent with a 1s-3d electronic 
transition. The pre-edge peak areas for both QueH samples are 2.68 and 2.54, 
Figure	3.4	
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Figure 3.4. QueH:Fe(II) binding model fits. QueH binds two Fe(II) ions. The 
absorption decay at 366 nm was used to fit for a 1:2 QueH:Fe(II) binding model using 
the program DYNAFIT from 3 different competition assays with varying ratios of 
QueH:mag-fura-2. ■ = 1:2 QueH:mag-fura-2; ● = 1:1 QueH:mag-fura2;  ◆ = 2:1 
QueH:mag-fura-2. Individual data points represent raw assay data. The lines 
represent the data fits used to obtain Kd values for both Fe(II) binding events (4.5 µM 
and 11.2 µM).  
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respectively (Figure 3.6 inset and Table 3.1), which suggest a symmetric, six coordinate 
system. Controls were done with Fe(II)SO4 and Fe(III)SO4 (not shown), which had peak 
inflections of 7124.1 and 7127.3 eV, respectively (Table 3.1). The first inflection points of 
the two samples of QueH are 7123.9 and 7124.0 eV, respectively (Figure 3.6 and Table 
3.1). These inflection points in the XANES, compared to the standards, confirms that 
QueH preferentially binds Fe(II) and not Fe(III).  
Figure 3.6. XANES spectra of QueH-Fe(II). Duplicate samples of QueH loaded with 2 
equivalents of Fe(II) are shown in black and blue. The first inflection points of the two 
samples are 7123.9 eV and 7124.0 eV, which correspond to the inflection point of an 
Fe(II) standard. The inset shows the pre-edge features between 7110 – 7115 eV for both 
samples. XAS data was collected at the Stanford Synchrotron Radiation Lightsource and 
analyzed by Brianne Lewis. 
F gure	3.5	
Figure 3.5. X-Ray Absorption Near Edge Structure (XANES) of QueH-Fe(II). 
Duplicate samples of QueH loaded with 2 equivalents of Fe(II) are shown in black 
and blue. The first inflection points of the two samples are 7123.9 eV and 7124.0 eV, 
which correspond to the inflection point of an Fe(II) standard. The inset shows the 
pre-edge features between 7110 – 7115 eV for both samples. XAS was conducted at 
the Stanford Synchrotron Radiation Lightsource and data was analyzed by Brianne 
Lewis. 
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Table 3.1. Fe-XANES analysis of pre-edge area and edge first-inflection points for 
QueH. 
 Pre-Edge Area 
(dimensionless) 
Peak-First Inflection 
Energy (eV) 
QueH Sample 1 2.68 7123.9 
QueH Sample 2 2.54 7124.0 
Fe(II)SO4 control 5.181 7124.1 
Fe(III)SO4 control 3.62 7127.3 
1 Published pre-edge area value for Fe(II) standard [80]. 
2 Published pre-edge area value for Fe(III) standard [81]. 
The extended X-Ray absorption fine structure (EXAFS) results for QueH are shown 
in Figure 3.7. Both samples of QueH bound to Fe(II) show similar iron ligation. Figure 
3.7 shows the raw, unfiltered Fe-EXAFS data (black line) and the best-fit simulations 
(green line) with a resolution of 0.13 Å. The best fit for both QueH samples and the 
statistical analysis are described in Table 3.2. QueH contains 3 Fe-O/N vectors with a 
bond length of 2.08 Å and an independent Fe-O/N vector at 2.19 Å. Long range Fe-C 
vectors were also observed with bond lengths of 3.17 Å and 3.75 Å for the two Fe(II) ions, 
respectively. These XAS data for QueH are consistent with a six-coordinate ferrous iron 
center dominated by O/N ligands with long range carbon scattering. In the model of QeuH 
there are 5 conserved cysteines that are clustered together, which is where we expected 
the two Fe(II) ions to bind; however, sulfur coordination was not observed in the EXAFS. 
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Figure 3.7. EXAFS analysis of QueH-Fe(II). Raw k3-weighted EXAFS data and phase 
shifted Fourier Transform (FT) are shown. A. EXAFS of QueH-Fe(II) sample 1 and B. FT 
of QueH-Fe(II) sample 1. C. EXAFS of QueH-Fe(II) sample 2 and D. FT of QueH-Fe(II) 
sample 2. The raw unfiltered data is shown in black and best-fit simulations are shown in 
green. XAS was conducted at the Stanford Synchrotron Radiation Lightsource and data 
was analyzed by Brianne Lewis.
Figure	3.6	
Figure 3.6. Extended X-Ray Absorption Fine Structure (EXAFS) of QueH-Fe(II). 
Raw k3-weighted EXAFS data and phase shifted Fourier Transform (FT) are shown. 
A. EXAFS of QueH-Fe(II) sample 1 and B. FT of QueH-Fe(II) sample 1. C. EXAFS of 
QueH-Fe(II) sample 2 and D. FT of QueH-Fe(II) sample 2. The raw unfiltered data is 
shown in black and best-fit simulations are shown in green. XAS was conducted at 
the Stanford Synchrotron Radiation Lightsource and data was analyzed by Brianne 
Lewis. 
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Table 3.2. Summary of Fe EXAFS simulations for QueH 
 Nearest-Neighbor Ligand 
Environment1 
Long-Range Ligand Environment1  
 Atom2 R (Å)3 C.N.4 s2 5 Atom2 R (Å)3 C.N.4 s2 5 F’ 6 
QueH 
Sample 1 
O/N 2.08 3.0 5.17 C 3.17 2.0 4.57 0.39 
 O/N 2.19 2.0 5.19 C 3.75 2.0 2.36  
QueH 
Sample 2 
O/N 2.05 3.0 3.82 C 3.16 3.0 4.86 0.38 
 O/N 2.19 3.0 4.31 C 3.59 2.0 4.97  
1 Independent metal-ligand scattering environment 
2 Scattering atoms: N (nitrogen), O (oxygen), C (carbon) 
3 Average metal-ligand bond length (+/-) 0.13 Å 
4 Average metal-ligand coordination number (+/-) 1.0 
5 Average Debye-Waller factor (Å x 103) 
6 Number of degrees of freedom weighted mean square deviation between data and fit 
3.2.4 QueH secondary structure does not change upon Fe(II) binding 
 Circular Dichroism (CD) spectra were collected for QueH with and without Fe(II) bound 
(Figure 3.8). The CD spectrum of Apo-QueH (Figure 3.8, black line) represents the first 
experimental structural analysis for QueH, since we only have a model structure for this 
enzyme generated by I-TASSER [47]. Values for the different secondary structures of 
QueH were determined using the COTIN method from 5 databases [82]. The final 
analysis parameters are shown in Table 3.3. QueH was determined to be 16.8% a-helix, 
28.6% b-sheet, 23.1% other secondary structure, and 31.6% disordered (Table 3.3). 
These values differ from those that were calculated from the model structure of QueH, 
suggesting that the model is inaccurate (Table 3.3). No significant structural changes 
were observed when 2 equivalents of Fe(II) were loaded onto QueH (Holo-QueH).  
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Figure 3.8. Circular dichroism of Apo-QueH and Holo-QueH. l = Apo-QeuH; l = 
Holo-QeuH (QueH loaded with 2 equivalents of Fe(II)). CD spectroscopy was conducted 
in an anaerobic chamber in Dr. Stemmler’s lab with Brianne Lewis. 
Table 3.3. Fitting parameters of Apo-QueH and Holo-QueH (QueH loaded with 2 
equivalents of Fe(II)) 
 a-helix b-sheet Other structured Disordered Fit 
Apo-QueH 16.8 ± 5.8 28.6 ± 4.9 23.1 ± 0.1 31.6 ± 1.1 0.06 
Holo-QueH 16.2 ± 5.8 28.7 ± 5.2 23.1 ± 0.2 32.1 ± 0.4 0.07 
Model of QueH1 42.1 3.3 ND ND ND 
1 Percentages for the model of QueH were calculated using the STRIDE server, a 
secondary structure assignment program [83]. ND = not determined.  
3.2.5 Epoxyqueuosine reductase activity of QueH 
We hypothesized that QueH uses its Fe(II)-binding sites to reduce epoxyqueuosine to 
queuosine. Twenty-eight different conditions were tested for epoxyqueuosine reductase 
Figure	3.7	
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Figure 3.7. Circular Dichroism of Apo-QueH and Holo-QueH. ● = Apo-QeuH; ● = 
Holo-QeuH (QueH loaded with 2 equivalents of Fe(II)). CD spectroscopy was 
conducted in an anaerobic chamber in Dr. Stemmler’s lab with Brianne Lewis. 
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activity in QueH. All assays were done in an anaerobic chamber and used tRNA purified 
from a DQueG E. coli strain. The conditions tested included varying the concentration of 
QueH, adding more than 2 equivalents of Fe(II), adding ATP, MgCl2, and EDTA. Figure 
3.9A shows the LC-MS traces for epoxyqueuosine and queuosine controls. Figure 3.9B 
shows the LC-MS traces for assays done with QueH and QueH loaded with 2 equivalents 
of Fe(II), only two of the conditions that were tested. In these LC-MS traces, only peaks 
corresponding to epoxyqueuosine were observed indicating that we were unable to 
recapitulate de Crécy-Lagard and co-workers’ results in vitro [48].
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Figure 3.9.  LC-MS of epoxyqueuosine reductase assays with QueH. A. Controls of 
epoxyqueuosine (EpoxyQ) and queuosine (Q). B. LC-MS traces of digested tRNA after 
assays with QueH alone versus QueH loaded with 2 equivalents of Fe(II) (QueH-2 Fe(II)). 
In both panels A and B, the top row shows traces for epoxyqueuosine and the bottom row 
shows traces for queuosine. LC-MS was collected by Rémi Zallot at the Carl R. Woese 
Institute for Genomic Biology at University of Illinois at Urbana-Champaign. 
Figure	3.8	
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Figure 3.8.  LC-MS of epoxyqueuosine reductase s ays with QueH. A. Controls 
of epoxyqueuosine (EpoxyQ) and qu uosine (Q). B. LC-MS traces of digested tRNA 
after assays with QueH alone versus QueH loaded with 2 quivalents of Fe(II) 
(QueH-2 Fe(II)). In both panels A and B, the top row shows traces for 
epoxyqueuosin  and the bottom row shows traces for queuosine. LC-MS was 
collected by Rémi Zallot at th  Carl R. Woese Institute for Genomic Biology at 
University of Illinois at Urbana-Champaign. 
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3.3 Discussion 
Recently, through comparative genomics, de Crécy-Lagard and coworkers identified 
the DUF208 protein family, which includes Sa2591 and Hp0100, as epoxyqueuosine 
reductases and named them QueH [48]. Queuosine is a hypermodified guanosine base 
found in 4 different tRNAs: tRNAAsn, tRNAAsp, tRNAHis, and tRNATyr [49]. In some 
organisms, like E. coli, the last step of queuosine biosynthesis is achieved by a 
cobalamin-dependent epoxyqueuosine reductase called QueG (Figure 1.8) [52]. 
However, there are many microorganisms that lack QueG, but still contain TGT, QueA, 
and queuosine in their tRNAs. This observation was used to guide the search for QueH 
[48]. QueH is not a homolog of QueG and it does not contain cobalamin [48]. Our lab had 
discovered Hp0100 (now H. pylori QueH) for its involvement in indirect tRNA 
aminoacylation before the report of QueH and Chapter 2 of this thesis focused on 
characterizing the ATPase activity of Sa2519 (now S. aureus QueH). We have 
unpublished data that show that these proteins contain two different ATPase active sites: 
an AANH-like domain that is activated by Glu-tRNAGln and P-loop domain that is activated 
by Asp-tRNAAsn [38].  
In the model structure of S. aureus QueH (Sa2591), there are 5 conserved cysteine 
residues clustered together that make up a putative metal binding site (Figure 3.2) [47]. 
Notably, there is a CXXC sequence, a known metal-kkkkkkbinding motif, in the P-loop 
ATPase active site of S. aureus QueH (Sa2591) (Figure 3.2). It cannot be a coincidence 
that QueH contains a putative metal biding site that could provide a path for 
epoxyqueuosine reduction and that this site is close to the P-loop ATPase active site, 
which is activated by Asp-tRNAAsn, a tRNA that contains queuosine. In this chapter, metal 
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binding by QueH was characterized through different spectroscopic techniques and we 
assayed S. aureus QueH for epoxyqueuosine reductase activity.  
We first tested several different metals for binding to S. aureus QueH, including; 
monovalent, divalent, and trivalent metal ions, via UV-visible spectroscopy wavelength 
scans. The only metal that gave a shift in its spectrum upon mixing with the protein 
compared to metal alone was Fe(II) (Figure 3.3A). This observation was the first 
evidence that S. aureus QueH is an Fe(II) binding metalloprotein.  
We then started a collaboration with Dr. Timothy Stemmler to further characterize the 
Fe(II) binding of S. aureus QueH. Dr. Stemmler has optimized an Fe(II) competition 
binding assay that utilizes the metal chelator mag-fura-2 [78]. This assay was used to 
calculate the stoichiometry of Fe(II) binding to S. aureus QueH and the Kd values for the 
binding event(s). When Fe(II) is titrated into a solution containing both S. aureus QueH 
and mag-fura-2, QueH competes with mag-fura-2 for Fe(II) binding, which causes a decay 
in mag-fura-2 absorption at 366 nm (Figure 3.4). This absorbance decrease was used to 
fit different models of Fe(II) binding to S. aureus QueH. Data from 3 competition binding 
assays, wherein the ratio of QueH:mag-fura-2 was varied, were fit to 3 different Fe(II) 
binding models (eq. 1 – 3). For each competition assay the data best fit a 1:2 QueH:Fe(II) 
binding model (Figure 3.5). The estimated Kd of both Fe(II) binding events are 4.5 ± 1.0 
µM and 11.2 ± 3.7 µM, respectively.  
Once the stoichiometry of binding had been determined, we obtained XAS data for S. 
aureus QueH bound to two Fe(II) ions to provide more insight into the local metal 
environment. There are two regions of XAS, XANES and EXAFS. The XANES region 
gives information about the metals oxidation state and geometry and the EXAFS region 
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gives insight specifically into metal-ligand interactions. The XANES data confirmed that 
the oxidation state of the iron bound to S. aureus QueH is Fe(II) and not Fe(III) (Figure 
3.6 and Table 3.1). The pre-edge peak areas in the two XANES spectra suggest that the 
geometry of the Fe(II) is a symmetric six-coordinate system with an octahedral geometry 
(Figure 3.6 and Table 3.1). The EXAFS showed that the ferrous iron center is dominated 
by O/N vectors with long range carbon scattering (Figure 3.7 and Table 3.2). From the 
model structure of S. aureus QueH, it was expected that the two Fe(II) ions would be 
coordinated by sulfurs from the conserved cysteine residues near the P-loop ATPase 
domain (Figure 3.2), possibly in an Fe-S cluster. The EXAFS spectra did not show sulfur 
coordination (Figure 3.7), inconsistent with this model. 
CD spectroscopy was also conducted with S. aureus QueH in its apo and holo state 
(Figure 3.8 and Table 3.3). From the model structure of S. aureus QueH, it was 
calculated that the protein is 42.1% a-helixes and 3.3% b-sheet. However, from the CD 
fitting parameters, it was calculated that S. aureus QueH is 16.8% a-helixes and 28.6% 
b-sheet (Table 3.3). CD spectroscopy was also performed with S. aureus QueH loaded 
with 2 equivalents of Fe(II) and there was no change in the secondary structure upon 
Fe(II) binding (Figure 3.8 and Table 3.3).  
From these experiments, we can conclude that S. aureus QueH is a metalloprotein 
that preferentially binds 2 Fe(II) ions using O/N ligands. We have hypothesized that QueH 
would use its 2 Fe(II) ions to reduce epoxyqueuosine to queuosine. de Crécy-Lagard and 
coworkers showed this activity in vivo by complementing different orthologs of QueH into 
a DQueG E. coli strain [48]. We wanted to recapitulate this activity in vitro and show that 
this activity is dependent on Fe(II) bound to QueH. For these experiments we began a 
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collaboration with Dr. Valérie de Crécy-Lagard and Dr. Rémi Zallot. Using tRNA that was 
purified from a DQueG E. coli strain, several different assay conditions were tested for S. 
aureus QueH epoxyqueuosine reductase activity, however, we were unable to see any 
evidence of queuosine formation (Figure 3.9).  
After obtaining the results from XAS and the negative epoxyqueuosine reductase 
assays, we resubmitted the sequence of S. aureus QueH to I-TASSER [47]. This time, 
two of the protein structures that I-TASSER used for model building were 2-thiouridine 
synthetase (TtuA) from two different organisms [45, 46]. Like QueH, TtuA is a tRNA 
modifying enzyme that contains a CXXC metal binding motif next to a P-loop ATPase 
domain. Recently, a new crystal structure of TtuA revealed a [4Fe-4S] iron-sulfur cluster 
that is coordinated by the two cysteines in the CXXC motif and another cysteine in the 
protein (Figure 3.10) [46]. The structural similarities between our QueH model and the 
TtuA crystal structure suggest an explanation for why XAS didn’t show any sulfur 
coordination and why the epoxyqueuosine reductase assays were unsuccessful. Our 
XAS data show the two Fe(II) ions that are bound to QueH coordinated to O/N ligands, 
leaving room for an incompletely formed Fe-S cluster.  In fact, Tanaka and coworkers had 
to reconstitute the [4Fe-4S] cluster in TtuA [46]. Thus, it seems probable that S. aureus 
QueH contains a mature [4Fe-4S] cluster in vivo that is involved in epoxyqueuosine 
reduction, explaining the ability of this enzyme to complement a ∆QueG E. coli strain [48]. 
Presumably, this activity was missing in our in vitro assays because we did not install this 
critical catalytic feature. Future experiments should focus on reconstituting the iron-sulfur 
cluster in S. aureus QueH and conducting CD and XAS experiments to see how the 
spectra change. Also, the likelihood is high that epoxyqueuosine reductase assays will 
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prove to be more informative when reexamined with S. aureus QueH with an intact iron-
sulfur cluster. There is always the possibility that the iron-sulfur cluster alone will not result 
in epoxyqueuosine reductase activity if it follows a mechanism similar to that of TtuA, 
which needs a sulfur donor from TtuB (Figure 1.9) [45, 46].  
Figure 3.10. Structural similarities between QueH and TtuA. A. Model of QueH 
showing the CXXC motif (C129 and C132) and a nearby conserved cysteine (C213). I-
TASSER has put C129 and C132 in a disulfide bond, however their oxidation states are 
unknown [47]. B. Structure of TtuA from T. thermophilus (PDB: 5b4e) showing the CXXC 
motif (C130 and C133) and nearby conserved cysteine (C222) that are coordinating a 
[4Fe-4S] iron-sulfur cluster [46]. C. Alignment of QueH model (cyan) and TtuA structure 
(green) showing the highly conserved cysteines overlay one another.   
Figur 	3.9	
Figure 3.9. Structural similarities of QueH and TtuA. A. Model of QueH showing 
the CXXC motif (C129 and C132) and a nearby conserved cystein  (C213). I-
TASSER has put C129 and C132 in a disulfide bond however, the oxidation state is 
unknown. B. Structure of TtuA from T. thermophilus (PDB: 5b4e) showing the CXXC 
motif (C130 and C133) and nearby conserved cysteine (C222) that are coordinating a 
[4Fe-4S] iron-sulfur cluster. C. Alignment of QueH model (cyan) and TtuA structure 
(green) showing the highly conserved cysteines overlay one another.   
C. Overlay of QueH (cyan) and TtuA (green)  
P-loop 
A. QueH model (cyan) 
C129 
C132 
C213 
P-loop 
B. TtuA structure (green) 
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P-loop 
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Given the similarities between our QueH model and TtuA, it is possible to propose a 
mechanism for QueH for future studies (Figure 3.11). In this mechanism, an activated 
sulfur atom will attack one of the carbon atoms in the epoxide ring of epoxyqueuosine, 
which will open the ring and allow for nucleophilic attack by the oxygen at the a-phosphate 
of ATP, activating this oxygen. The activated sulfur atom (R1 in Figure 3.11) could be 
attached to several different sources. For example, one of the Fe(II) ions that is attached 
to QueH, to the probable iron-sulfur cluster that is in QueH, a persulfide, or possibly a 
protein partner similar to TtuB delivering an activated sulfur to TtuA. In the intermediate 
step, a second activated sulfur atom would attack the first sulfur atom creating a disulfide 
bond, allowing for the reduction of the carbon-carbon bond and AMP as the leaving group. 
This would produce the desired product, queuosine. The second activated sulfur atom 
(R2 in Figure 3.11) could be attached to any of the options listed above for R1 however, 
it is most likely from a free cysteine residue in the active site of QueH. From Figure 3.1, 
there are 5 cysteine residues clustered together near the P-loop ATPase domain: C129, 
C132, C209, C211, and C213. From the alignment of our QueH model and TtuA (Figure 
3.10), the 3 cysteine residues that would be involved in coordinating the iron-sulfur cluster 
would be C129, C132, and C213. This arrangement would allow for either C209 or C211 
to act as the second activated sulfur in the reduction of epoxyqueuosine to queuosine.  
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Figure 3.11. Proposed mechanism for epoxyqueuosine reduction by S. aureus  
QueH. R1 could be several different sources such as Fe(II) coordinated to the protein, an 
iron-sulfur cluster, a persulfide, or a protein partner. R2 could be any of the above or, most 
likely, a free cysteine in the active site of QueH. In our proposed mechanism, an activated 
sulfur atom would attack one of the carbons in the epoxide ring, which will allow for oxygen 
activation by ATP. Another activated sulfur atom will attack the first sulfur forming a 
disulfide bond, which allows for reduction of the C-C bond and AMP as the leaving group.  
3.4 Materials and Methods 
3.4.1 Materials 
 Hepes and ATP were purchased from GoldBio Biotechnology, Inc., (St. Louis, MO). 
Mag-fura-2, tris(2-carboxyethyl)phosphine (TCEP), EDTA, NaCl, and MgCl2 were 
purchased from ThermoFisher Scientific (Hampton, NH). Fe(NH4)2(SO4)2, b-
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Figure 3.10. Propos d mechanism for xyqueuosine reduction by S. aureus  
QueH. R1 could be several different sources such as; Fe(II) coordinated to the 
protein, an iron-sulfur cluster, a persulfide, or a protein partner. R2 could be any of the 
above or most likely a free cysteine in the active site of QueH. An activated sulfur 
atom will attack one of the carbons of the epoxide ring, which will allow for oxygen 
activation by ATP. Another activated sulfur atom will attack the first sulfur forming a 
disulfide bond, which allows for reduction of C-C bond and AMP as the leaving group.  
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mercaptoethanol, and all metal compounds were purchased from Sigma Aldrich (St. 
Louis, MO).  
3.4.2 Overexpression and purification of S. aureus QueH (Sa2591) 
 S. aureus  QueH (Sa2591) was overexpressed and purified as described in Chapter 2. 
After The His6-tagged TEV protease was removed from QueH by passing the reaction 
through a HiTrap Chelating HP affinity column, the flow through containing QueH was 
dialyzed against 1 L dialysis buffer C (20 mM Hepes, pH 7.5, 300 mM NaCl, 5 mM b-
mercaptoethanol) twice for 1 hour each time. S. aureus QueH was concentrated using an 
Amicon 10 kDa MWCO tube (EMD Millipore, Burlington, MA) and protein concentration 
was calculated as described in Chapter 2.  
3.4.3 Assessing metal-binding to S. aureus QueH using UV-Vis spectroscopy 
UV-Vis wavelength scans were obtained on a Beckman DU800 spectrophotometer 
from 250 – 700 nm under aerobic conditions. Metal solutions (2 mM) were made fresh in 
degassed water prior to each experiment. Scans of 0.5 mM metal in 100 mM Hepes 
buffer, pH 7.4 were done with and without 20 µM QueH. The metal solution was mixed 
with QueH by pipetting up and down and UV-Vis scans were immediately taken at room 
temperature to minimize oxidation. The different metal solutions that were tested are as 
follows: FeSO4, FeCl2, FeCl3, CuCl, CuCl2, ZnSO4, NiSO4, MgCl2, MnCl2, and MnSO4. 
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3.4.4 Fe(II) competition binding assay 
 The Fe(II) competition binding assays were conducted in Dr. Timothy Stemmler’s lab 
located in the Pharmacy School at Wayne State University with Brianne Lewis. The 
competition assays were performed as previously described [78] except for the following 
changes. Samples were prepared in 20 mM HEPES, pH 7.5, 300 mM NaCl and 5 mM 
TCEP. All reagents/buffers except for the protein were Ar (g) purged and equilibrated 
overnight in a wet anaerobic chamber. After purification of S. aureus QueH and dialysis 
into buffer C as described above, the protein was equilibrated in a wet anaerobic chamber 
for 1 hour/mL of sample. The absorbance at 366 nm was corrected for dilution and used 
to calculate binding parameters using DYNAFIT. Binding data were fit using a non-linear 
least squares analysis script to calculated the Fe(II) stoichiometry and Kd of the binding 
event(s). Each reaction was simulated using one, two, and three-site binding models.   
3.4.5 X-Ray absorption spectroscopy (XAS) 
 Full Fe XAS data were collected by Dr. Timothy Stemmler at the Stanford Synchrotron 
Radiation Lightsource (SSRL) on beamline 9-3. Duplicate samples of S. aureus QueH 
were loaded with 2 equivalents of Fe(II) (1.2 mM Fe(NH4)2(SO4)2) in a buffer of 20 mM 
Hepes, pH 7.5, 300 mM NaCl, 5 mM TCEP. The samples were stored in liquid nitrogen 
prior to beam exposure. Approximately four scans were collected on each sample, which 
were averaged together to obtain the final analysis. This analysis was performed by 
Brianne Lewis.    
3.4.6 Circular dichroism spectroscopy of S. aureus QueH 
 CD spectra of 50 µM apo-QueH and holo-QueH (QueH loaded with 2 equivalents of 
Fe(II)) in 20 mM Hepes, pH 7.5, 300 mM NaCl were prepared in a Coy wet anaerobic 
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chamber. Spectra were collected using a 0.01 cm anaerobic quartz cuvette on a Jasco 
1500 spectrophotometer with a Peltier VT unit set at room temperature. Ten scans were 
taken for each sample with triplicate QueH samples purified from 3 different colonies 
(biological replicates). A baseline was subtracted to eliminate buffer signal. Data were 
analyzed using the Jasco CD Pro analysis software and simulated using the CONTIN 
method (with the SP29, SP37, SP43, SMP50 and SMP56 reference sets) [82]. Values 
obtained from simulations using each database were averaged to obtain final analysis 
parameters.		 
3.4.7 Total tRNA purification 
 Transfer RNA (tRNA) was purified from a DqueG E. coli strain that was provided by Dr. 
Rémi Zallot [48]. Purification of the tRNA was performed as previously described [23].  
3.4.8 Epoxyqueuosine reduction assay 
The tRNA was refolded by heating to 75 °C and cooling to 65 °C, at which point MgCl2 
was added to a final concentration of 2 mM and the tRNA was slowly cooled to room 
temperature. The refolded tRNA, S. aureus QueH, and all other reagents were 
equilibrated in an anaerobic chamber located in Dr. Stemmler’s lab for 1 – 2 hours prior 
to use. All assays were performed in this chamber. S. aureus QueH was loaded with 2 
equivalents of Fe(II) using a fresh solution of Fe(NH4)2(SO4)2. All reactions contained 200 
µg tRNA, 1 µM S. aureus QueH with or without Fe(II) and 4 mM MgCl2 and were 
performed in a buffer containing 20 mM Hepes, pH 7.5, 300 mM NaCl, 5 mM b-
marcaptoethanol. Several different reaction conditions were tested which included: 
adding 2 mM ATP, 0.2 mM EDTA, 5 µM Fe(NH4)2(SO4)2, 10 µM Fe(NH4)2(SO4)2, using 
100 nM S. aureus QueH (instead of 1 µM), and adding 1 µL of lysate from DQueG E. coli 
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in varying combinations Reactions were mixed in the anaerobic chamber and initiated 
with S. aureus QueH at which point the reaction tubes were sealed and removed from the 
chamber and incubated at 37 °C for 1 hour. The reactions were quenched with 5 mM 
EDTA and put into a -80 °C freezer. The tRNA was enzymatically digested to individual 
nucleosides as previously described [48]. Liquid chromatography-mass spectrometry and 
analysis was performed by Dr. Rémi Zallot at the Carl R. Woese Institute for Genomic 
Biology at University of Illinois at Urbana-Champaign. 
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CHAPTER 4: TRANSFER RNA-INDUCED PRODUCTION OF ADP BY MANY 
AMINOACYL-TRNA SYNTHETASES 
The majority of this chapter has been submitted for publication and is under review. 
4.1 Introduction 
The aminoacyl-tRNA synthetases (aaRSs) are central to protein biosynthesis because 
each of these enzymes catalyzes the attachment of a single amino acid to its cognate 
tRNA(s), usually with high substrate specificity (Figure 1.1A). Their products, the 
aminoacyl-tRNAs (aa-tRNAs), are subsequently used in protein biosynthesis by the 
ribosome (Figure 1.1B). All aaRSs consume ATP en route to their aa-tRNA products via 
two reactions (Figure 1.2). First, the cognate amino acid (specific to a given aaRS) is 
condensed with ATP to produce an aminoacyl-adenylate (aa-AMP), releasing PPi 
(reaction 1). Next, the activated amino acid is transferred to its cognate tRNA, to produce 
the aa-tRNA and AMP (reaction 2). This dependence on ATP and production of AMP 
was elucidated for the yeast methionyl-tRNA synthetase (MetRS) and rat liver leucyl-
tRNA synthetase (LeuRS) in the 1950’s [84, 85]. We now know that these reactions are 
evolutionarily conserved across all three domains of life and all known aaRSs [3-5]. 
aaRS + aa + ATP à aaRS•aa-AMP + PPi                (Rxn 1) 
aaRS•aa-AMP + tRNAaa à aaRS + aa-tRNA + AMP             (Rxn 2) 
 Despite sharing the same reaction pathways, the aaRS are divided into two classes 
(Class I and Class II), based on the structure of their active sites. The aaRSs can also be 
further divided into subclasses based on their structures and various functional 
idiosyncrasies (Table 1.2) [4, 5].  
We are unaware of published or anecdotal evidence that aaRSs can produce ADP 
instead of AMP. We recently discovered this activity serendipitously when using H. pylori 
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GluRS2 (a misacylating glutamyl-tRNA synthetase used in indirect tRNA aminoacylation 
[9, 14]) and its substrates glutamate and tRNAGln to produce AMP as a positive control 
for a TLC assay, when the unexpected production of ADP was observed.  
To determine whether this activity was unique to GluRS2 or represented an activity 
intrinsic to aaRSs, we screened 25 different aaRSs from three different bacterial species, 
including all 20 E. coli aaRSs, for their ability to produce ADP from ATP in the presence 
of tRNA. Remarkably, we’ve identified a number of aaRSs that are capable of robustly 
generating ADP in the presence of tRNA. Possible functional roles for this activity are 
discussed. 
4.2 Results 
4.2.1 H. pylori GluRS2 produces ADP from ATP 
In a paper published by our group [23], we investigated the phosphorylation of 
aminocylated-tRNAs by GatCAB, the amidotransferase that uses glutamine as an 
ammonia donor to transamidate misacylated tRNAs (Asp-tRNAAsn and Glu-tRNAGln) to 
the correctly aminoacylated tRNAs (Asn-tRNAAsn and Gln-tRNAGln, respectively) [23]. 
GatCAB uses ATP to activate its two misacylated tRNA substrates by phosphorylating 
the side chain of the non-cognate amino acid while it is attached to the tRNA [23]. The 
side product of this phosphorylation reaction is ADP. In an effort to more sensitively 
observe initial phosphorylation rates for this reaction, we set out to develop a radiolabeled 
thin layer chromatography (TLC) assay using a-32P-ATP as the GatCAB substrate with 
Glu-tRNAGln. Radiolabelled TLC controls were needed for a-32P-ADP and a-32P-AMP. 
Protein kinase A and kemptide [86] were used for the a-32P-ADP control and an 
aminoacylation assay using H. pylori GluRS2 (a misacylating glutamyl-tRNA synthetase 
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that produces Glu-tRNAGln [9, 14]) with H. pylori tRNAGln and glutamate was used for the 
a-32P-AMP control. Unexpectedly, phosphorimaging of the TLC revealed the presence of 
a-32P-ADP as a product of H. pylori GluRS2 (Figure 4.1). To our knowledge, this is the 
first time that any aaRS has been shown to produce ADP instead of AMP, the expected 
product. 
Figure 4.1. H. pylori GluRS2 produces ADP from ATP. a-32P-ATP and a-32P-ADP were 
separated by TLC in 1 M LiCl2. Lane 1, Protein kinase A and kemptide plus a-32P-ATP as 
an ADP positive control. Lane 2, H. pylori GluRS2 with Glu and H. pylori tRNAGln plus a-
32P-ATP.  
H. pylori GluRS2 is distinct among the aaRSs because it only misacylates tRNAGln 
with glutamate [9, 14]. However, GluRS2 has a protein partner, called GluRS1, a 
discriminating GluRS that aminoacylates tRNAGlu with glutamate [9, 14]. To investigate if 
ADP production was an activity unique to GluRS2, we performed the same radiolabelled 
TLC assay with GluRS1 (Figure 4.2). For this experiment glutamate was omitted to avoid 
making the Glu-AMP intermediate and Glu-tRNAGlu. Like GluRS2, GluRS1 hydrolyzed 
ATP to ADP and, to our surprise, the addition of deacylated H. pylori tRNAGlu1 stimulated 
Figure	4.1	
ATP 
ADP 
1 2 
AMP 
Figure 4.1. H. pylori GluRS2 produces ADP from ATP. α-32P-ATP and α-32P-ADP 
were separated by TLC in 1 M LiCl2. Lane 1, Protein Kinase A and Kemptide plus 
α-32P-ATP as an ADP positive control. Lane 2, H. pylori GluRS2 with Glu and H. 
pylori tRNAGln plus α-32P-ATP.  
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ADP production (Figure 4.2). These results confirm that ADP is produced by both GluRS1 
and GluRS2.  
Figure 4.2. H. pylori GluRS1 produces ADP in a tRNA- and time-dependent manner. 
A. a-32P-ATP and a-32P-ADP were separated by TLC in 1 M LiCl2. Lane 1, Protein kinase 
A and kemptide plus a-32P-ATP as an ADP positive control. Lanes 2-10, H. pylori GluRS1 
alone with a-32P-ATP, time points taken over 10 min. Lanes 11-19, H. pylori GluRS1 + H. 
pylori tRNAGlu1 with a-32P-ATP, time points taken over 10 min. Time points were taken at 
0, 1, 2, 3, 4, 5, 6, 8, and 10 min. Note: Neither assay contained glutamate. B. a-32P-ATP 
and a-32P-ADP spots on the TLC in panel A were quantified using the densitometry 
function in ImageQuant software (GE Healthcare Life Sciences, Pittsburgh, PA, USA). 
Rates were determined from a plot of pmoles ADP produced over time. l = GluRS1 alone 
(y = 1.0X + 91.1); n = GluRS1 + tRNAGlu1 (y = 12.2X + 95.6). Note: At time point = 0 min, 
the starting ADP is ~95 pmoles, due to contaminating ADP in the a-32P-ATP sample.  
To more thoroughly and broadly examine this activity, we turned to a facile enzyme-
coupled assay for ADP detection. This continuous, spectrophotometric assay provides 
initial rates for ATP hydrolysis to ADP and Pi [21]. ADP production is coupled to NADH 
oxidation via pyruvate kinase and lactate dehydrogenase with phosphoenolpyruvate and 
NADH as substrates, respectively. A decrease in absorbance at 340 nm (due to NADH 
oxidation) directly correlates to ADP production (Figure 2.5A). Importantly, oxidation of 
NADH does not occur in the presence of either ATP or AMP (Figure 2.5B), demonstrating 
Figure 4.2
Figure 4.2. H. pylori GluRS1 produces ADP in a tRNA- and time-dependent
manner. A. a-32P-ATP and a-32P-ADP were separated by TLC in 1 M LiCl2. Lane 1,
Protein Kinase A and Kemptide plus a-32P-ATP as an ADP positive control. Lanes 2-
10, H. pylori GluRS1 alone with a-32P-ATP, time points taken over 10 min. Lanes 11-
19, H. pylori GluRS1 + H. pylori tRNAGlu1 with a-32P-ATP, time points taken over 10
min. Note: Neither assay contained glutamate. B. a-32P-ATP and a-32P-ADP spots
on the TLC in panel A were quantified using densitometry function in ImageQuant
software (GE Healthcare Life Sciences, Pittsburgh, PA, USA). Rates were
determined from a plot of pmoles ADP produced over time. l = GluRS1 alone (y =
1.0X + 91.1); 1 + tRNAGlu1 (y = 12. X + 95.6) Note: At time point = 0 min
the starting ADP is ~95 pmoles, due to contaminating ADP in the a-32P-ATP sample.
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that this assay is specific for ADP. We used this assay to more quantitatively characterize 
ADP production by GluRS1 and GluRS2 and to determine if other aaRSs involved in 
indirect tRNA aminoacylation also have the capacity to produce ADP.   
The aaRSs involved in indirect tRNA aminoacylation from H. pylori and M. smegmatis 
were analyzed for their rates of ADP production with their specific tRNA substrates (Table 
4.1). Hp GluRS1 was examined with tRNAGlu1 as its representative tRNA substrate. 
(GluRS1 also aminoacylates the Hp tRNAGlu2 isoacceptor [9, 14].) Hp GluRS2 is 
specifically a misacylating aaRS that solely produces Glu-tRNAGln; consequently, it was 
examined with tRNAGln specifically [9, 14]. H. pylori ND-AspRS is a non-discriminating 
aspartyl-tRNA synthetase that aminoacylates both tRNAAsp and tRNAAsn with aspartate to 
make the correctly aminoacylated product Asp-tRNAAsp and the misacylated product Asp-
tRNAAsn, respectively [13]. ND-AspRS was tested with both H. pylori tRNAAsp and tRNAAsn. 
We also examined the two non-discriminating aaRSs from M. smegamits (ND-GluRS and 
ND-AspRS) specifically with their non-cognate tRNA substrates, tRNAGln and tRNAAsn, 
respectfully.  
Four different assays were performed with each enzyme/tRNA pair, in triplicate from 
biological replicates: (1) aaRS alone; (2) aaRS with tRNA; (3) aaRS with cognate amino 
acid and tRNA; and, (4) aaRS with cognate amino acid. Table 4.1 lists the observed rates 
of ADP production for these five aaRSs with respect to basal activity and the impact of 
tRNA on ADP production (Assays 1-3). (Rates of ADP production for assays with aaRS 
plus cognate amino acid were uniformly slow and demonstrated that the addition of amino 
acid had little effect on ADP production (Assay 4, Table 4.2).) 
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All five enzymes (100 nM) were capable of slowly producing ADP from ATP in the 
absence of tRNA, with rates ranging from 0.62 µM/min (Ms ND-GluRS) to 1.13 µM/min (Hp 
GluRS2 and ND-AspRS). These rates increased by 1.9- to 27.3-fold in the presence of 
specific tRNAs. The highest increases were observed with the two M. smegmatis aaRSs, 
Ms-ND-GluRS (27.3-fold) and ND-AspRS (5.7-fold), with their non-cognate tRNAGln and 
tRNAAsn substrates, respectively. Interestingly, tRNAAsp and tRNAAsn similarly, and only 
weakly, stimulated ADP production by Hp ND-AspRS (1.9- and 2.3-fold for final rates of 
2.15 and 1.57 µM/min, respectively) (Figure 4.3). Surprisingly, the addition of amino acid 
under conditions expected to favor tRNA aminoacylation has no significant effect on rates 
of ADP production (Table 4.1).  
Figure 4.3. Hp tRNAAsp and Hp tRNAAsn weakly stimulate ADP production by Hp ND-
AspRS. ATPase assays with H. pylori ND-AspRS with A. H. pylori tRNAAsp and B. H. 
pylori tRNAAsn are shown. All assays were conducted with overexpressed tRNA. Error 
bars represent standard deviation from triplicate measurements (biological replicates). 
See Table 4.1 above and Table 4.2 for rates. l = Hp ND-AspRS alone; n = Hp ND-
AspRS + Hp tRNAAsp/Asn; u = Hp ND-AspRS + Asp + Hp tRNAAsp/Asn; ▲ = Hp ND-AspRS 
+ Asp.  
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Figure 4.3. Hp tRNAAsp and Hp tRNAAsn weakly stimulate ADP production by Hp 
ND-AspRS. ATPase assays with H. pylori ND-AspRS with A. H. pylori tRNAAsp and 
B. H. pylori tRNAAsn are shown. All assays were conducted with overexpressed tRNA. 
Error bars represent standard deviation from triplicate measurements (biological 
replicates). See Table 4.1 above and Table 4.2 for rates. ● = Hp ND-AspRS alone; ■ 
= Hp ND-AspRS + Hp tRNAAsp/Asn; ◆ = Hp ND-AspRS + Asp + Hp tRNAAsp/Asn; ▲ = 
Hp ND-AspRS + Asp.  
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Table 4.1. Rate of ATP hydrolysis to ADP and Pi for aaRSs involved in indirect tRNA 
aminoacylation in H. pylori and M. smegmatis.  
aaRS tRNA1 
Rate of ADP Production (µM/min)2 
tRNA 
impact4 aaRS + tRNA 
aaRS + 
tRNA & 
aa3 
aaRS 
alone 
Hp ND-AspRS tRNAAsp 2.15 ± 0.40 1.87 ± 0.12 1.13 ± 0.07 1.9 
Hp ND-AspRS tRNAAsn 1.57 ± 0.11 1.88 ± 0.30 0.68 ± 0.16 2.3 
Hp GluRS1 tRNAGlu1 2.19 ± 0.38 2.42 ± 0.52 0.83 ± 0.16 2.6 
Hp GluRS2 tRNAGln 3.01 ± 0.31 2.81 ± 0.55 1.13 ± 0.13 2.7 
Ms ND-AspRS tRNAAsn 4.41 ± 0.19 4.13 ± 0.22 0.78 ± 0.54 5.7 
Ms ND-GluRS tRNAGln 16.9 ± 1.6 15.8 ± 1.3 0.62 ± 0.84 27.3 
1 Each tRNA was overexpressed in E. coli and quantified with the appropriate aaRS. The 
final tRNA stock solutions are contaminated with total E. coli tRNA (tRNA, 10 µM). 
2 Errors represent standard deviations from biological replicates of each enzyme. 
3 Each enzyme was assayed in the presence of its cognate amino acid (aa, 100 µM). 
4 The impact of tRNA on the rate of ADP production was calculated by dividing the rate 
observed with tRNA by that observed in the absence of tRNA.  
Table 4.2. ADP production by misacylating aaRSs in the absence of tRNA 
aaRS 
Rate of ADP 
Production (µM/min) aa impact2 
+ aa1 aaRS alone 
Hp ND-AspRS 1.41 1.13 ± 0.13 1.25 
Hp ND-AspRS 0.99 0.68 ± 0.16 1.46 
Hp GluRS1 1.22 0.83 ± 0.16 1.47 
Hp GluRS2 0.78 1.13 ± 0.13 0.69 
Ms ND-AspRS 1.62 0.8 ± 0.5 2.08 
Ms ND-GluRS 1.52 0.6 ± 0.8 2.45 
1 Cognate amino acid (100 µM) was used with each enzyme. 
2 aa impact was determined by dividing the +aa rate by the rate observed in the absence 
of aa. 
4.2.2 Many E. coli aaRSs produce ADP in the presence of tRNA 
 To assess if ADP production is an activity ubiquitous across the aaRS, we next 
screened all 20 E. coli aaRSs for ADP production using the spectrophotometric assay 
described above and the same series of four assays per enzyme. A 20-fold range of rates 
were observed across this series (Table 4.3). Figure 4.4 shows comparative rates for the 
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enzyme with the slowest quantifiable, basal rate in the presence of tRNA (HisRS), an 
average enzyme (TyrRS), and the fastest enzyme (LeuRS). The complete data set of 
rates from triplicate measurements are provided in Table 4.3 listed in order from fastest 
to slowest rate measured in the presence of total E. coli. Results from the ATPase assays 
for all 25 aaRSs that were screened in this study can be found at the end of this chapter 
(Figure 4.8A-Z). 
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Figure 4.4. The E. coli aaRSs exhibit a 20-fold range of rates for ADP production 
under the assay conditions used herein. Results from ATPase assays with different E. 
coli aaRS are shown; the depletion in NADH concentration directly correlates to ATP 
hydrolysis to ADP + Pi. A. E. coli HisRS; B. E. coli TyrRS; and, C. E. coli LeuRS. All 
assays were conducted with total E. coli tRNA. Error bars represent standard deviation 
from triplicate measurements. See Table 4.3 and 4.4 for rates. l = aaRS alone; n = 
aaRS + tRNA; u = aaRS + aa + tRNA; ▲ = aaRS + aa.
Figure	4.4	
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Figure 4.4. The E. coli aaRSs exhibit a 20-fold range of rates for ADP 
production. Results from ATPase assays with different E. coli aaRS are shown; the 
depletion in NADH concentration is directly related to ATP hydrolysis to ADP + Pi. A. 
E. coli HisRS; B. E. coli TyrRS; and, C. E. coli LeuRS. All assays were conducted 
with total E. coli tRNA. Error bars represent standard deviation from triplicate 
measurements. See Table 4.3 and 4.4 for rates. ● = aaRS alone; ■ = aaRS + tRNA; 
◆ = aaRS + aa + tRNA; ▲ = aaRS + aa. 
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Table 4.3. Rates of ATP hydrolysis to ADP and Pi for the 20 E. coli aaRSs. 
aaRS 
Rate of ADP Production (µM/min)1 tRNA 
impact4 aaRS + tRNA2 
aaRS + 
tRNA & aa3 aaRS alone 
LeuRS 36.3 ± 0.9 35.0 ± 0.9 0.60 ± 0.10 60.5 
ValRS 23.0 ± 2.0 25.4 ± 1.4 1.00 ± 0.14 23.0 
PheRS 19.5 ± 0.9 19.2 ± 0.6 0.52 ± 0.12 37.5 
AlaRS 17.7 ± 1.6 17.5 ± 1.1 0.36 ± 0.01 49.1 
GlyRS 17.5 ± 2.4 17.8 ± 2.2 0.42 ± 0.08 41.7 
ThrRS 10.6 ± 0.4 12.5 ± 1.6 1.57 ± 0.07 6.8 
CysRS 9.7 ± 2.1 11.1 ± 0.6 1.59 ± 0.28 6.1 
ProRS 9.3 ± 4.7 9.3 ± 3.8 0.47 ± 0.75 19.8 
AspRS 9.1 ± 0.3 7.7 ± 2.1 0.25 ± 0.12 36.0 
GlnRS 7.7 ± 2.5 8.9 ± 2.3 1.87 ± 0.14 4.1 
AsnRS 7.1 ± 1.5 7.1 ± 1.5 1.66 ± 0.08 4.3 
ArgRS 6.6 ± 1.3 5.8 ± 2.5 1.15 ± 0.09 5.5 
TyrRS 4.6 ± 1.7 4.2 ± 1.5 0.14 ± 0.02 32.9 
SerRS 4.2 ± 1.5 3.5 ± 1.3 0.20 ± 0.06 21 
IleRS 3.1 ± 0.6 2.7 ±0.7 1.10 ± 0.17 2.8 
TrpRS 2.9 ± 1.6 2.3 ± 1.1 0.21 ± 0.09 13.8 
MetRS 2.12 ± 0.26 2.43 ± 0.86 1.25 ± 0.02 1.7 
GluRS 1.91 ± 0.28 1.29 ± 0.57 0.88 ± 0.16 2.2 
HisRS 1.85 ± 0.16 1.39 ± 0.24 1.35 ± 0.20 1.4 
LysRS 1.80 ± 0.19 1.68 ± 0.24 0.00 ± 0.07 ND 
1 Errors represent standard deviations from biological replicates of each enzyme. 
2 Total E. coli tRNA was used with an estimated concentration of 10 µM for each 
isoacceptor.  
3 Each enzyme was assayed in the presence of its cognate amino acid (100 µM).  
4 The impact of tRNA on the rate of ADP production was calculated by dividing the rate 
observed with tRNA by that observed in the absence of tRNA.
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Table 4.4. ADP production by E. coli aaRSs in the absence of tRNA 
aaRS 
Rate of ADP Production 
(µM/min) aa impact2 
aaRS alone + aa1 
LeuRS 0.60 ± 0.10 0.62 1.03 
AlaRS 0.36 ± 0.01 0.18 0.50 
CysRS 1.59 ± 0.28 1.26 0.79 
AspRS 0.25 ± 0.12 0.10 0.40 
GluRS 0.88 ± 0.16 1.27 1.44 
PheRS 0.52 ± 0.12 0.53 1.02 
GlyRS 0.42 ± 0.08 0.35 0.83 
HisRS 1.35 ± 0.20 1.15 0.85 
IleRS 1.10 ± 0.17 1.13 1.03 
LysRS 0.00 ± 0.07 0.06 ND 
MetRS 1.25 ± 0.02 1.36 1.09 
AsnRS 1.66 ± 0.08 1.66 1.00 
ProRS 0.47 ± 0.75 1.24 2.64 
GlnRS 1.87 ± 0.14 1.73 0.93 
ArgRS 1.15 ± 0.09 1.23 1.07 
SerRS 0.20 ± 0.06 0.14 0.70 
ThrRS 1.57 ± 0.07 1.76 1.12 
ValRS 1.00 ± 0.14 0.72 0.72 
TrpRS 0.21 ± 0.09 0.19 0.90 
TyrRS 0.14 ± 0.02 0.14 1.00 
1 Cognate amino acid (100 µM) was used with each enzyme. 
2 aa impact was determined by dividing the +aa rate by the rate observed in the absence 
of aa.  
 E. coli LysRS was the slowest enzyme overall with a tRNA-dependent rate of 1.80 
µM/min in the presence of tRNA and an essentially undetectable rate in the absence of 
tRNA that approximated zero. E. coli LeuRS showed the highest rate overall in the 
presence of tRNA. (36.3 µM/min), but not in the absence of tRNA (0.60 µM/min), 
amounting to a 60.5-fold increase in ADP production in the presence of tRNA.  GlnRS 
showed the fastest rate of ADP production in the absence of tRNA with a rate of 1.87 
µM/min; however, the addition of tRNA in this case had only a 4.1-fold effect, increasing 
the rate of ADP production to 7.7 µM/min. These observed rates show that the 20 E. coli 
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aaRSs exhibit a 20-fold range in rates of ATP hydrolysis to ADP and Pi. Clearly, ADP 
production by the discriminating E. coli aaRSs are also dependent on deacylated tRNA. 
Further, they demonstrate that this activity is highly varied across the aaRSs.  
4.2.3 Rates of ADP production for the 20 E. coli aaRSs show a pattern among the 
subclasses 
 The E. coli aaRSs show a wide range of rates for ADP production when assayed with 
total E. coli tRNA, ranging from 1.8 – 36.3 µM/min (Table 4.3). These rates were arranged 
by aaRS subclass into a bar graph (Figure 4.5). The aaRSs with the most robust rates of 
ADP production cluster into subclasses Ia, IIa, and IIc.  
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Figure 4.5. Rate of ADP production by the 20 E. coli aaRSs. The E. coli aaRSs are 
grouped into their different subclasses. Rates of ADP production are from assays with 
aaRS + total E. coli tRNA. Error bars represent standard deviation from biological 
replicates, n = 3 for each enzyme except for ProRS where n = 4.  
4.2.4 ADP production rates vary across species 
 AspRS from three different organisms, E. coli, H. pylori, and M. smegmatis, were 
compared for their rates of ADP production using the enzyme-coupled ATPase assays 
(Figure 4.6). It is worth noting that E. coli AspRS is a discriminating aaRS (D-AspRS) and 
was assayed with total E. coli tRNA, while the H. pylori and M. smegmatis AspRSs are 
non-discriminating (ND-AspRS) and were assayed with their species-specific tRNAAsn. E. 
coli AspRS demonstrates the fastest rate at 9.1 µM/min (Table 4.3 and Figure 4.6), 
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Figure 4.5. Rate of ADP production by the 20 E. coli aaRSs. The E. coli aaRSs 
are grouped into their different subclasses. Rates of ADP production are from assays 
with aaRS + total E. coli tRNA. Error bars represent standard deviation from 
biological replicates, n = 3 for each enzyme except for ProRS where n = 4.  
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compared to rates of 1.6 to 4.4 µM/min for Hp ND-AspRS and Ms ND-AspRS, respectively 
(Table 4.1 and Figure 4.6).  
Figure 4.6. Comparison of ADP production rates for AspRS from different species. 
AspRS from H. pylori and M. smegmatis are non-discriminating aaRSs and were assayed 
using species-specific tRNAAsn. E. coli AspRS is a discriminating and was assayed with 
total E. coli tRNA. A. H. pylori ND-AspRS; B. M. smegmatis ND-AspRS; C. E. coli D-
AspRS. l = aaRS alone; n = aaRS + tRNA; u = aaRS + aa + tRNA; ▲ = aaRS + aa. 
See Tables 4.1, 4.2, 4.3, and 4.4 for rates. 
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Figure 4.6. Comparison of ADP production rates for AspRS from different 
species. AspRS from H. pylori and M. smegmatis are non-discriminating aaRSs and 
were assayed using species-specific tRNAAsn, whereas from E. coli it is a 
discriminating aaRS and was assayed with total E. coli tRNA. A. H. pylori ND-AspRS; 
B. M. smegmatis ND-AspRS; C. E. coli AspRS. ● = aaRS alone; ■ = aaRS + tRNA; 
◆ = aaRS + aa + tRNA; ▲ = aaRS + aa. See Tables 4.1, 4.2, 4.3, and 4.4 for rates. 
See Figure S4 for an analogous comparison among different GluRSs. 
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We also conducted a similar comparison across four different GluRS species from 
three organisms (Figure 4.7). H. pylori utilizes two different GluRS orthologs, one that 
glutamylates tRNAGlu1 and tRNAGlu2 (GluRS1), and another that specifically misacylates 
tRNAGln with glutamate (GluRS2) [9, 14]. M. smegmatis has one ND-GluRS (a non-
discriminating aaRS) that aminoacylates tRNAGlu and tRNAGln with glutamate, and E. coli 
has a D-GluRS (a discriminating aaRS) that only glutamylates tRNAGlu isoacceptors. A 
comparison of these four enzymes with different tRNA substrates reveals that the Ms ND-
GluRS is the fastest ADP producer across this series with a rate of 16.9 µM/min (Table 
4.1 and Figure 4.7). The three other enzymes (Hp GluRS1, Hp GluRS2, and Ec D-GluRS) 
all show similar, slow rates of ADP production between 1.91 and 3.0 µM/min. These 
comparisons suggest that, while ADP production is conserved across species, the rates 
of this activity are not.  
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Figure 4.7. Comparison of ADP production rates for GluRS from different species. 
GluRS from M. smegmatis is a non-discriminating aaRS. H. pylori uses GluRS1 and 
GluRS2 to glutamylated tRNAGlu1 and tRNAGlu2 versus tRNAGln, respectively. E. coli uses 
a D-GluRS. These enzymes were assayed using species-specific tRNAs (Hp tRNAGlu1, 
Hp tRNAGln, Ms tRNAGln, and Ec total tRNA). A. E. coli D-GluRS; B. H. pylori GluRS1; C. 
H. pylori GluRS2; and, D. M. smegmatis ND-GluRS. l = aaRS alone; n = aaRS + tRNA; 
u = aaRS + aa + tRNA; ▲ = aaRS + aa. For rates, see Tables 4.1, 4.2, 4.3, and 4.4.
Figure	4.7	
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Figure 4.7. Comparison of ADP productio  rates for GluRS fr m different 
species. GluRS from M. smegm tis is a non-discriminating aaRS. H. pylori uses 
GluRS1 and GluRS2 to glutamylated tRNAGlu1 and tRNAGlu2 versus tRNAGln, 
respectively. E. coli uses a D-GluRS. These enzymes were assayed using species-
specific tRNAs (Hp tRNAGlu1, Hp tRNAGln, Ms tRNAGln, and Ec total tRNA). A. E. coli 
D-GluRS; B. H. pylori GluRS1; C. H. pylori GluRS2; and, D. M. smegmatis ND-
GluRS. ● = aaRS alone; ■ = aaRS + tRNA; ◆ = aaRS + aa + tRNA; ▲ = aaRS + aa. 
For rates, see Tables 4.1, 4.2, 4.3, and 4.3. 
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4.2.5 Examination of enzyme components for autophosphorylation 
To determine whether the aaRSs were catalyzing an auto-phosphorylation reaction, in 
the presence of deacylated tRNA, g-32P-ATP (2.5 Ci/mol), and tRNA were co-incubated 
over 30 minutes and analyzed by phosphorimaging. No evidence of auto-phosphorylation 
was obtained (data not shown).  
4.3 Discussion  
 It is well established that aaRSs catalyze the ATP-dependent esterification of an amino 
acid to its cognate tRNA, simultaneously producing AMP and PPi [3-5]. We are unaware 
of any evidence that aaRSs can produce ADP instead of AMP. However, we 
serendipitously discovered this activity when using H. pylori GluRS2 with glutamate and 
tRNAGln to produce AMP as a positive control on a TLC (Figure 4.1). Building on this 
discovery, twenty-five aaRSs from three different organisms were screened for ADP 
production activity in the present work. This activity seems to be ubiquitous among all 
aaRSs, albeit to varying extents. The data presented herein allow for a number of 
interesting comparisons to be made.   
The E. coli aaRSs show rates of ADP production in the presence of tRNA that span a 
20-fold range (from 1.8-36.3 µM/min, Table 4.3), with the rates of the aaRSs from H. 
pylori and M. smegmatis falling on the lower end of this scale (with rates from 1.6-16.9 
µM/min, Table 4.1). The rates of the E. coli enzymes have been grouped by enzyme 
subclass in Figure 4.5. Notably, the aaRSs with the most robust activities fall in 
subclasses Ia and IIa, with the exception of PheRS, which is in subclass IIc. It has been 
proposed that the aaRSs evolved in pairs across the two classes [57, 87, 88]. The 
observation that ADP production rates also group by subclass suggests that this activity 
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may have emerged prior to fixation of the genetic code when the aaRSs still shared close 
connections across classes.  
Many aaRSs have editing activities that promote accurate tRNA aminoacylation in the 
presence of near-cognate amino acids. LeuRS and ValRS are class I aaRSs with well-
characterized editing activities and they also exhibit the highest rates of ADP production 
(36.3 and 23.0 µM/min, respectively), suggesting a possible connection between editing 
and ATP hydrolysis to ADP. This hypothesis is belied by the fact that IleRS, another Class 
I aaRS that edits, exhibits one of the lowest rates of ADP production (3.1 µM/min). A 
similar disconnect is observed between Class II aaRS that edit and their ATPase 
activities. For example, GlyRS has a high rate of ATPase activity but no known editing 
activity. These comparisons suggest that ADP production evolved separately and 
independently from editing activity; nevertheless, it will be important to reexamine these 
rates of ADP production in future work to determine if the addition of non-cognate amino 
acids has any effect.  
We can also draw conclusions from a comparison of ATPase activities across species. 
When comparing AspRS from 3 different species, it is interesting that the rate of ADP 
production by E. coli D-AspRS is faster than the rate for either H. pylori or M. smegmatis 
ND-AspRS (Figure 4.6). In contrast, M. smegmatis ND-GluRS is faster than either H. 
pylori GluRS1 or GluRS2 or E. coli D-GluRS (Figure 4.7). These comparisons argue that 
ADP production is not connected to the relaxed tRNA specificity of non-discriminating 
aaRSs. It is worth noting that in the assays with the H. pylori and M. smegmatis aaRSs, 
species-specific tRNAs were used and in the assays with E. coli aaRSs, total E. coli tRNA 
was used.  
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In general, the observed basal rates for each enzyme and those measured in the 
presence of amino acid alone proved to be fairly low and uninteresting. What is 
unexpected is the fact that the addition of amino acid and tRNA did not statistically impact 
the observed rates of ADP production in nearly any case. These conditions would be 
expected to favor tRNA aminoacylation exclusively and yet ATP hydrolysis to ADP 
continued undisrupted. While we don’t yet understand this observation, it may offer a clue 
to why aaRSs hydrolyze ATP to ADP. We hypothesize that this activity may represent a 
stress response in vivo (discussed further below). Perhaps, some specific condition of 
our assays inadvertently recapitulates the conditions needed in vivo to trigger ADP 
production. There is the possibility that this activity may not be relevant in vivo however, 
with the varying rates amongst the different aaRSs it suggests that there is some in vivo 
relevance for this ADP production.  
In an effort to understand why this activity exists, we considered possible roles that 
might be played by each of the two products: Pi and ADP. First, we examined a selection 
of E. coli aaRSs (AsnRS, GlnRS, IleRS, and MetRS) for evidence of autophosphorylation. 
Exhaustive attempts to observe enzyme phosphorylation through the use of radiolabeled 
ATP were unsuccessful however, leading us to conclude that autophosphorylation is not 
occurring.  
  The well-established stringent pathway senses amino acid starvation using 
deacylated tRNA as a signaling molecule [89]. Because deacylated tRNAs also trigger 
ADP production by the aaRSs, we considered the possibility that elevations in ADP 
concentrations could offer another signal for amino acid starvation. However, this 
scenario seems unlikely, because different aaRSs all produce ADP indiscriminately. 
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Instead, we hypothesize that ADP production by the aaRSs could contribute to persister 
cell formation in the presence of deacylated tRNAs. Bacterial persisters are a 
subpopulation of microbial cells that are in a dormant state, which causes them to be 
tolerant to bactericidal antibiotics [90]. Several reports have demonstrated that a drop in 
intracellular ATP concentration can trigger persister cell formation [91-93]. Perhaps, when 
bacteria are under stress, the aaRSs bind to deacylated tRNAs to stimulate ATP 
hydrolysis to ADP and Pi, lowering intracellular ATP and inducing a persister state. Such 
a scenario offers a tantalizing possible explanation for this unexpected, yet ubiquitous, 
aaRS activity.  
4.4 Materials and Methods 
4.4.1 Materials 
Antibiotics, isopropyl b-D-thiogalactopyranoside (IPTG), phenylmethanesulfonyl 
fluoride (PMSF), Hepes, ATP, dithiothreitol (DTT) and lysozyme were purchased from 
GoldBio Biotechnology, Inc., (St. Louis, MO). Nicotinamide adenine dinucleotide (NADH), 
phosphoenolpyruvate (PEP), pyruvate kinase (PK), L-lactate dehydrogenase (LDH), and 
NaH2PO4 were purchased from Sigma Aldrich (St. Louis, MO). Polyethylenimine (PEI) 
cellulose thin-layer chromatography (TLC) plates were purchase from EMD Millipore 
(Burlington, MA). Yeast extract, peptone, NaCl, glycerol, sodium dodecyl sulfate (SDS), 
and imidazole were purchased from Fisher Scientific (Hampton, NH). a-32P-ATP and g-
32P-ATP were purchased from American Radiolabeled Chemicals, Inc. (St. Louis, MO).  
4.4.2 Protein overexpression and purification 
Unless otherwise stated, all aaRS were overexpressed in E. coli Bl21(DE3) RIL by 
inoculating a 100 mL culture of Luria-Bertani (LB) medium supplemented with 0.5% 
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glucose and the appropriate antibiotic (Table 4.5) with a 1 mL overnight culture grown in 
the same medium. Each culture was incubated at 37 °C with shaking at 225 rpm until the 
optical density (OD) at 600 nm reached 0.4-0.6 (unless otherwise stated). Protein 
expression was induced with 1 mM IPTG. Each culture was grown at 37 °C for 4 hours 
with shaking at 225 rpm. Cells were harvested by centrifugation. All non-discriminating 
aaRSs were grown until the OD at 600 nm reached 0.8-1.0, then protein expression was 
induced with 1 mM IPTG. Each culture was harvested after 1 hour of overexpression at 
37 °C.  
Each cell pellet was suspended in 400 µL equilibration buffer (50 mM NaH2PO4, pH 
7.4, 300 mM NaCl, 10 mM imidazole) and lysozyme was added to a final concentration 
of 2 mg/mL. The suspension was incubated on ice for 30 min. An aliquot of a saturated 
solution of PMSF (7.5 µL) was added every 15 min to reduce proteolysis. Sonication was 
performed 6 times using a Misonix Microson™ Ultrasonic Cell Disruptor set at power level 
4 for 10 seconds, with 50 second rest cycles on ice between each pulse. The lysate was 
clarified by centrifugation at 14,000 rpm for 30 min at 4 °C. Proteins were purified following 
the manufacture’s protocol for HisPur Ni-NTA spin columns (ThermoScientific, Rockford, 
IL) with the following modifications: the equilibration buffer contained 50 mM NaH2PO4 
and the wash buffer contained 20 mM imidazole. Each aaRS was dialyzed against and 
concentrated in dialysis buffer (50 mM NaH2PO4, pH 7.4, 300 mM NaCl) using a 0.5 mL 
Amicon 30 KDa molecular weight cut-off filter (EMD Millipore, Burlington, MA). Proteins 
were judged to be >95% pure by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). Each enzyme was stored in 50% glycerol and used within 
a week of purification. Each protein concentration was determined by UV-Vis 
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spectroscopy at 280 nm, using Beer’s law and an extinction coefficient that was 
determined using the ExPASy ProtParam tool within the Proteomics server [74]. Each 
aaRS was grown and purified in triplicate from three different colonies (biological 
replicates). 
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 Table 4.5. Summary of plasmids used in this study. 
aaRS1 Vector Antibiotic resistance marker Reference 
Ec AlaRS pQE30 Ampicillin  [94] 
Ec ArgRS pET16b Ampicillin [94] 
Ec AsnRS Unknown Ampicillin Unknown 
Ec AspRS pET21a Ampicillin [94] 
Ec CysRS pET21a Ampicillin [94] 
Ec GlnRS pSJW1 Ampicillin [95] 
Ec GluRS pET21a Ampicillin [94] 
Ec GlyRS pET21a Ampicillin [94] 
Ec HisRS pET21a Ampicillin [94] 
Ec IleRS pKS21 Ampicillin [96] 
Ec LeuRS pET21a Ampicillin [94] 
Ec LysRS pET21a Ampicillin [94] 
Ec MetRS pET28a Kanamycin [97] 
Ec PheRS pQE30 Ampicillin [94] 
Ec ProRS pET21a Ampicillin [94] 
Ec SerRS pET21a Ampicillin [94] 
Ec ThrRS pQE30 Ampicillin [94] 
Ec TrpRS pET21a Ampicillin [94] 
Ec TyrRS pET21a Ampicillin [94] 
Ec ValRS pET21a Ampicillin [94] 
Hp ND-AspRS pQE80L Ampicillin [13] 
Hp GluRS1 pQE80L Ampicillin [9] 
Hp GluRS2 pQE80L Ampicillin [9] 
Ms ND-AspRS pET28a Kanamycin Kindly provided by 
Babak Javid 
Ms ND-GluRS pET28a Kanamycin Kindly provided by 
Babak Javid 
tRNA1 Vector Antibiotic resistance marker Reference 
Hp tRNAAsp pES300 Ampicillin [13] 
Hp tRNAAsn pES300 Ampicillin [13] 
Hp tRNAGlu1 pES300 Ampicillin [9] 
Hp tRNAGln pES300 Ampicillin [9] 
Ms tRNAAsn pES300 Ampicillin Kindly provided by 
Babak Javid 
Ms tRNAGln pES300 Ampicillin Kindly provided by 
Babak Javid 
1 Vectors were kindly provided by Professors Rebecca Alexander, Babak Javid, John 
Perona, and Takuya Ueda. 
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4.4.3 tRNA overexpression and purification 
 M. smegmatis tRNAAsn and tRNAGln, H. pylori tRNAAsn, tRNAAsp, tRNAGln, and tRNAGlu1 
were overexpressed in the E. coli strain MV1184, purified, folded and quantified by 
aminoacylation assay as previously described [23]. This approach provides tRNA that is 
highly enriched in the overexpressed isoacceptor but also contains total E. coli tRNA. For 
assays with E. coli aaRSs, total E. coli tRNA was isolated from 1 L E. coli MV1184 in LB 
medium supplemented with 0.5% glucose. The culture was incubated at 37 °C with 
shaking at 225 rpm until the optical density (OD) at 600 nm reached 0.4-0.6 at which point 
the cells were harvested by centrifugation (mid-log phase). Total E. coli tRNA was isolated 
from this cell pellet as described [23]. The concentration of the total tRNA was calculated 
by UV-Vis spectroscopy at 260 nm assuming 1 OD = 1.6 µM. This number was divided 
by 20 to approximate the concentration for each tRNA isoacceptor.  
4.4.4 Thin-layer chromatography 
 ATPase assays for H. pylori GluRS1 and GluRS2 were performed using a-32P-ATP 
and the hydrolysis products were separated by TLC. These assays were performed at 37 
°C in reaction buffer containing 40 mM Hepes, pH 7.5, 4 mM ATP, 2.5 Ci/mol a-32P-ATP, 
and 8 mM MgCl2. In assays that contained tRNA, 10 µM species-specific isoacceptor 
tRNA was used and in assays that contained amino acid, 100 µM cognate amino acid 
was used. Each assays was initiated with 1 µM aaRS and 5 µL aliquots were taken at 0, 
1, 2, 3, 4, 5, 6, 8, and 10 min and quenched into 5 µL of ice-cold 2x quench buffer (20 
mM NH2OH, 50 mM EDTA, 50 mM Hepes, pH 7.5). Spots (2 µL) were made 1 cm apart 
on PEI cellulose TLC plates and the TLC was run in 1 M LiCl2. Once the buffer was 1 cm 
from the top of the TLC, the plate was dried and developed on a Molecular Dynamics 
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Storage Phosphor screen overnight and imaged on a Typhoon FLA 9500 Biomolecular 
Imager (GE Healthcare Life Sciences, Pittsburgh, PA, USA). Quantification was 
conducted using ImageQuant software (GE Healthcare Life Sciences). 
4.4.5 Enzyme assays to quantify ADP production 
 ATPase assays were performed as previously described [21]. This assays monitors 
ATP hydrolysis to ADP + Pi specifically by coupling ADP production to the oxidation of 
NADH to NAD+. The decrease in NADH can be monitored over time at 340 nm and is 
directly correlated to the production of ADP (Figure 2.5). Four different assays were 
conducted for each aaRS: (1) 100 nM aaRS alone; (2) 100 nM aaRS and ~10 µM cognate, 
species-specific tRNA; (3) 100 nM aaRS, 0.1 mM cognate amino acid, and 10 µM tRNA; 
and, (4) 100 nM aaRS and 0.1 mM cognate amino acid. All assays were conducted in 
triplicate from different enzyme purifications, except for assay 4 (enzyme + amino acid), 
which was only measured once per aaRS. Assays were performed in a Beckman Coulter 
DU800 spectrophotometer, recording absorbance readings at 340 nm every 2 or 5 
seconds for a total of 5.5 minutes. Assays were initiated with the addition of the aaRS 
only after the absorbance at 340 nm had stabilized. Data were averaged and plotted as 
absorbance versus time. The y-intercept of the assay with aaRS only (assay 1) was used 
to calculate the initial NADH concentration with 6,220 M-1 cm-1 as the extinction coefficient 
[77]. This concentration was then used to normalize the starting NADH concentration for 
all other assays conducted with the same aaRS. This normalization was necessary 
because the tRNA has a background absorbance at 340 nm, presumably due to the 
presence of a post-transcriptional modification. 
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4.4.6 Autophosphorylation analysis 
 Assays using g-32P-ATP were conducted to investigate if the aaRSs ATPase activity 
caused autophosphorylation of the protein. These assays were performed at 37 °C in 
reaction buffer containing 40 mM Hepes, pH 7.5, 4 mM ATP, 2.5 Ci/mol g-32P-ATP, and 
8 mM MgCl2. In assays that contained tRNA, ~10 µM cognate total E. coli tRNA was used. 
Each assay was initiated with 1 µM aaRS (E. coli AsnRS, GlnRS, IleRS, and MetRS) and 
incubated at 37 °C for 30 minutes, at which time a 20 µL aliquot was quenched into 20 
µL of ice-cold 2x quench buffer (20 mM NH2OH, 50 mM EDTA, 50 mM Hepes, pH 7.5). 
SDS-PAGE loading buffer (50 mM Tris-HCl, pH 6.8, 100 mM DTT, 2% SDS, 0.1% 
bromophenol blue, 10% glycerol) was added to the sample and boiled for 10 minutes 
before running on a 12% SDS-PAGE. After the gel was done running, it was soaked in 
3% glycerol, 40% methanol, 10% acetic acid for 1 hour before drying on a BioRad Model 
583 gel dryer at 70 °C for 1 – 2 hours. The gel was developed on a Molecular Dynamics 
Storage Phosphor screen overnight and imaged on a Typhoon FLA 9500 Biomolecular 
Imager (GE Healthcare Life Sciences).  
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Figure 4.8. ATPase assays for all 25 aaRSs that were screened as part of this work. 
A. – Z. Figures are listed in the order they are presented in Table 4.1 and 4.2. l = aaRS 
alone; n = aaRS + tRNA; u = aaRS + aa + tRNA; ▲ = aaRS + aa.  
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y = 53.746 - 1.1608x   R2= 0.99749 
y = 53.746 - 2.8848x   R2= 0.99537 
y = 53.745 - 2.7176x   R2= 0.99713 
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Ms ND-AspRS alone AVG
Ms ND-AspRS + Ms tRNAAsn AVG
Ms ND-AspRS + Asp + Ms tRNAAsn AVG
Ms ND-AspRS + Asp
y = 54.419 - 0.87382x   R2= 0.9913 
y = 54.42 - 4.4134x   R2= 0.99993 
y = 54.42 - 4.1204x   R2= 0.99991 
y = 54.419 - 1.6536x   R2= 0.99421 
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Ms ND-GluRS + Glu
y = 47.882 - 0.58304x   R2= 0.99584 
y = 47.887 - 17.706x   R2= 0.99543 
y = 47.877 - 16.432x   R2= 0.99633 
y = 47.88 - 1.5924x   R2= 0.99436 
N
A
D
H
 (µ
M
)
Time (min)
E. 
F. 
 
 
107 
 
0
10
20
30
40
50
60
0 1 2 3 4 5
Ec LeuRS ATPase
Ec LeuRS alone AVG
Ec LeuRS + Ec tRNA AVG
Ec LeuRS + Leu + Ec tRNA AVG
Ec LeuRS + Leu
y = 53.903 - 0.59764x   R2= 0.99858 
y = 53.909 - 35.947x   R2= 0.99638 
y = 53.9 - 34.513x   R2= 0.99745 
y = 53.903 - 0.6365x   R2= 0.99781 
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Ec ValRS alone AVG
Ec ValRS + Ec tRNA AVG
Ec ValRS + Val + Ec tRNA AVG
Ec ValRS + Val
y = 39.626 - 1.0123x   R2= 0.99671 
y = 39.62 - 23.518x   R2= 0.99725 
y = 39.638 - 24.946x   R2= 0.99423 
y = 39.625 - 0.73448x   R2= 0.99232 
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Ec PheRS ATPase
Ec PheRS alone AVG
Ec PheRS + Ec tRNA AVG
Ec PheRS + Phe + Ec tRNA AVG
Ec PheRS + Phe
y = 37.649 - 0.57455x   R2= 0.99387 
y = 37.656 - 19.867x   R2= 0.99276 
y = 37.648 - 18.415x   R2= 0.99265 
y = 37.649 - 0.5857x   R2= 0.96322 
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Ec AlaRS ATPase
Ec AlaRS alone AVG
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Ec AlaRS + Ala + Ec tRNA AVG
Ec AlaRS + Ala
y = 53.818 - 0.4139x   R2= 0.94967 
y = 53.819 - 17.512x   R2= 0.99425 
y = 53.819 - 17.439x   R2= 0.99759 
y = 53.819 - 0.21323x   R2= 0.89818 
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Ec GlyRS ATPase
Ec GlyRS alone AVG
Ec GlyRS + Ec tRNA AVG
Ec GlyRS + Gly + Ec tRNA AVG
Ec GlyRS + Gly
y = 47.346 - 0.43806x   R2= 0.98433 
y = 47.348 - 17.08x   R2= 0.9963 
y = 47.345 - 17.304x   R2= 0.99826 
y = 47.345 - 0.35718x   R2= 0.97335 
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Ec ThrRS ATPase
Ec ThrRS alone AVG
Ec ThrRS + Ec tRNA AVG
Ec ThrRS + Thr + Ec tRNA AVG
Ec ThrRS + Thr
y = 49.318 - 1.8146x   R2= 0.98388 
y = 49.313 - 9.6175x   R2= 0.98987 
y = 49.314 - 11.938x   R2= 0.99023 
y = 49.319 - 1.7929x   R2= 0.99856 
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Ec CysRS ATPase
Ec CysRS alone AVG
Ec CysRS + Ec tRNA AVG
Ec CysRS + Cys + Ec tRNA AVG
Ec CysRS + Cys
y = 50.996 - 1.645x   R2= 0.99728 
y = 50.992 - 9.4932x   R2= 0.99066 
y = 51.002 - 10.757x   R2= 0.9926 
y = 50.997 - 1.3252x   R2= 0.99109 
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Ec ProRS ATPase
Ec ProRS alone AVG
Ec ProRS + Ec tRNA AVG
Ec ProRS + Pro + Ec tRNA AVG
Ec ProRS + Pro
y = 43.679 - 0.48137x   R2= 0.99214 
y = 43.687 - 10.632x   R2= 0.99764 
y = 43.68 - 9.9627x   R2= 0.98724 
y = 43.68 - 1.2707x   R2= 0.9944 
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Ec AspRS ATPase
Ec AspRS alone AVG
Ec AspRS + Ec tRNA AVG
Ec AspRS + Asp + Ec tRNA AVG
Ec AspRS + Asp
y = 51.993 - 0.25596x   R2= 0.96236 
y = 51.988 - 8.2662x   R2= 0.99869 
y = 51.99 - 7.6918x   R2= 0.99779 
y = 51.993 - 0.13706x   R2= 0.88533 
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Ec GlnRS ATPase
Ec GlnRS alone AVG
Ec GlnRS + Ec tRNA AVG
Ec GlnRS + Gln + Ec tRNA AVG
Ec GlnRS + Gln
y = 71.682 - 1.9195x   R2= 0.99159 
y = 71.684 - 6.12x   R2= 0.99515 
y = 71.678 - 7.3206x   R2= 0.9947 
y = 71.682 - 1.8311x   R2= 0.98223 
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Ec AsnRS ATPase
Ec AsnRS alone AVG
Ec AsnRS + Ec tRNA AVG
Ec AsnRS + Asn + Ec tRNA AVG
Ec AsnRS + Asn
y = 67.767 - 1.869x   R2= 0.98669 
y = 67.77 - 5.9089x   R2= 0.99348 
y = 67.769 - 5.7779x   R2= 0.99055 
y = 67.768 - 1.6575x   R2= 0.98787 
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Ec ArgRS ATPase
Ec ArgRS alone AVG
Ec ArgRS + Ec tRNA AVG
Ec ArgRS + Arg + Ec tRNA AVG
Ec ArgRS + Arg
y = 50.959 - 1.1655x   R2= 0.9989 
y = 50.964 - 6.5814x   R2= 0.99004 
y = 50.956 - 5.7001x   R2= 0.99217 
y = 50.959 - 1.2871x   R2= 0.99338 
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Ec TyrRS ATPase
Ec TyrRS alone AVG
Ec TyrRS + Ec tRNA AVG
Ec TyrRS + Tyr + Ec tRNA AVG
Ec TyrRS + Tyr
y = 45.865 - 0.16676x   R2= 0.88014 
y = 45.872 - 5.0757x   R2= 0.99727 
y = 45.864 - 4.3045x   R2= 0.99664 
y = 45.866 - 0.20551x   R2= 0.74042 
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Ec SerRS ATPase
Ec SerRS alone AVG
Ec SerRS + Ec tRNA AVG
Ec SerRS + Ser + Ec tRNA AVG
Ec SerRS + Ser
y = 46.72 - 0.24253x   R2= 0.93842 
y = 46.715 - 3.8521x   R2= 0.99674 
y = 46.724 - 3.6071x   R2= 0.99762 
y = 46.72 - 0.13775x   R2= 0.91693 
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Ec IleRS ATPase
Ec IleRS alone AVG
Ec IleRS + Ec tRNA AVG
Ec IleRS + Ile + Ec tRNA AVG
Ec IleRS + Ile
y = 70.195 - 1.1172x   R2= 0.99826 
y = 70.198 - 2.9382x   R2= 0.99017 
y = 70.187 - 2.6419x   R2= 0.98853 
y = 70.195 - 1.1515x   R2= 0.99655 
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Ec TrpRS ATPase
Ec TrpRS alone AVG
Ec TrpRS + Ec tRNA AVG
Ec TrpRS + Trp + Ec tRNA AVG
Ec TrpRS + Trp
y = 55.467 - 0.23077x   R2= 0.95051 
y = 55.472 - 2.5644x   R2= 0.99468 
y = 55.466 - 2.3119x   R2= 0.99437 
y = 55.467 - 0.19861x   R2= 0.93503 
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Ec MetRS ATPase
Ec MetRS alone AVG
Ec MetRS + Ec tRNA AVG
Ec MetRS + Met + Ec tRNA AVG
Ec MetRS + Met
y = 45.153 - 1.2974x   R2= 0.9956 
y = 45.15 - 2.1041x   R2= 0.99561 
y = 45.155 - 2.4295x   R2= 0.99648 
y = 45.152 - 1.4972x   R2= 0.97945 
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Ec GluRS ATPase
Ec GluRS alone AVG
Ec GluRS + Ec tRNA AVG
Ec GluRS + Glu + Ec tRNA AVG
Ec GluRS + Glu
y = 43.755 - 0.9029x   R2= 0.99462 
y = 43.756 - 1.9039x   R2= 0.99454 
y = 43.758 - 1.3592x   R2= 0.98419 
y = 43.756 - 1.3565x   R2= 0.98258 
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Ec HisRS ATPase
Ec HisRS alone AVG
Ec HisRS + Ec tRNA AVG
Ec HisRS + His + Ec tRNA AVG
Ec HisRS + His
y = 44.486 - 1.4096x   R2= 0.99512 
y = 44.482 - 1.8881x   R2= 0.99507 
y = 44.488 - 1.4396x   R2= 0.98265 
y = 44.487 - 1.25x   R2= 0.98129 
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Ec LysRS ATPase
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Ec LysRS + Lys + Ec tRNA AVG
Ec LysRS + Lys
y = 53.08 - 0.011753x   R2= 0.12948 
y = 53.084 - 1.7821x   R2= 0.98814 
y = 53.082 - 1.7538x   R2= 0.99012 
y = 53.08 + 0.0066728x   R2= 0.0049152 
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS 
5.1 Introduction 
 The work presented in this thesis focuses on enzymes involved in bacterial protein 
translation. In Chapter 2, a novel enzyme from S. aureus, Sa2591, was investigated for 
its involvement in indirect tRNA aminoacylation. In Chapter 3, the metal-binding domain 
of Sa2591 was characterized and its enzymatic function in tRNA modification was 
examined. In Chapter 4, a newly discovered activity of the aaRSs was presented and 
possible functional roles of this activity were discussed.  
 The first step in protein translation requires the aaRSs, which catalyze the esterification 
of their cognate amino acids onto their cognate tRNAs in an ATP-dependent manner, 
producing AMP and PPi as side products (Figure 1.1 and 1.2) [1, 3]. These enzymes are 
generally responsible for ensuring translational fidelity [1-3]. However, several bacteria 
do not contain a full set of 20 aaRSs and therefore must use a two-step, indirect pathway 
to aminoacylate some tRNAs [2, 4, 6, 7]. Many bacteria lack asparaginyl-tRNA synthetase 
and/or glutaminyl-tRNA synthetase (AsnRS and/or GlnRS) and cannot directly produce 
Asn-tRNAAsn or Gln-tRNAGln, respectively. In the absence of AsnRS or GlnRS, an indirect 
pathway is used to aminoacylate these tRNAs [2, 6, 7]. The first step utilizes an ND-
AspRS or ND-GluRS, which have relaxed tRNA specificities and are able to aminoacylate 
their cognate tRNA and specific non-cognate tRNAs with either aspartate or glutamate 
e.g., ND-AspRS will produce Asp-tRNAAsp and Asp-tRNAAsn and ND-GluRS will produce 
Glu-tRNAGlu and Glu-tRNAGln. In the second step of the indirect pathway the misacylated 
intermediates, Asp-tRNAAsn and Glu-tRNAGln, are corrected by an amidotransferase 
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called GatCAB. GatCAB uses glutamine as an ammonia donor for the transamidation of 
Asp-tRNAAsn to Asn-tRNAAsn and Glu-tRNAGln to Gln-tRNAGln (Figure 1.3) [2, 4, 6-11].  
 The misacylated intermediates from the indirect tRNA aminoacylation pathway must 
be prevented from entering the ribosome where they could cause translation errors at 
asparagine and glutamine codons [13, 27, 28]. To this end, one mechanism utilizes the 
formation of a ribonucleoprotein complex called the Asn-transamidosome [32-34]. In T. 
thermophilus this structure is comprised of two ND-AspRS, two GatCAB, and 4 tRNAAsn 
molecules, which allows for the efficient misacylation and transamidation of Asp-tRNAAsn, 
while limiting its misuse by the ribosome (Figure 1.5) [32, 33]. An analogous structure 
has not been found in H. pylori; instead the H. pylori Asn-transamidosome is tRNA-
independent and assembles via a protein factor called, Hp0100 [34-36]. Our lab 
discovered Hp0100 from a yeast two-hybrid assays that showed relevant connections to 
both ND-AspRS and GatCAB (Figure 1.6) [37]. We demonstrated that Hp0100 is 
necessary for H. pylori Asn-transamidosome assembly (Figure 1.7) and that Hp0100 
increases the transamidation rate of Asp-tRNAAsn by GatCAB ~35-fold [34]. Dr. Gayathri 
Silva has unpublished data showing that Hp0100 also increases the transamidation rate 
of Glu-tRNAGn by GatCAB ~3-fold [38]. Hp0100 contains two distinct ATPase active sites 
that are stimulated by different substrates: An AANH-like domain that is activated by Glu-
tRNAGln and a P-loop domain that is activated by Asp-tRNAAsn (Figure 2.1) [38].  
 Full-length orthologs of Hp0100 are restricted to the e-proteobacteria however, 
truncated versions are found outside of this clade. Chapters 2 and 3 focus on an ortholog 
of Hp0100 from S. aureus called Sa2591. This ortholog is comprised of the first 2/3 of the 
N-terminus of Hp0100 and contains both ATPase active sites, the AANH and P-loop 
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domain (Figure 2.2 and 2.3). Since Sa2591 shares sequence and structural homology 
with Hp0100, we wanted to investigate if Sa2591 is also an ATPase and determine its 
involvement in indirect tRNA aminoacylation.  
5.2 Sa2591 is a metalloprotein involved in indirect tRNA aminoacylation and is a 
probable tRNA modification enzyme 
 The initial characterization of Sa2591 as a functional ortholog of Hp0100 is the main 
focus of Chapter 2. When purifying Sa2591, we noticed that a co-purifying protein at the 
molecular weight of E. coli D-AspRS (~66 kDa). Aminoacylation assays suggests that this 
protein is E. coli D-AspRS (Figure 2.4), offering our first indication that Sa2591 is a 
functional ortholog of Hp0100. We also investigated the ATPase activity of Sa2591 and 
observed that its activity is only stimulated in the presence of misacylated tRNAs that 
were expressed in vivo and are consequently post-transcriptionally modified (Figure 2.6); 
misacylated tRNA transcripts were ineffective. The sequence, structural, and functional 
similarities between Hp0100 and Sa2591 suggest that they are functional orthologs. 
Future experiments would include investigating if Sa2591 is required for the formation of 
a S. aureus Asn-transamidosome analogous to the H. pylori Asn-transamidosome. 
Experiments are currently being conducted by Udumbara Rathnayake to see if Sa2591 
increases the transamidation rates of Asp-tRNAAsn to Asn-tRNAAsn and Glu-tRNAGln to 
Gln-tRNAGln by GatCAB. Future experiments also need to further characterize the impact 
of modified versus transcribed tRNAs. 
 In our model structure of Sa2591, there are 5 conserved cysteines clustered together 
near the P-loop ATPase domain, including a CXXC motif (Figure 3.2) [47]. Chapter 3 
describes the characterization of this putative metal binding domain. In the initial 
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characterization, several mono-, di-, and trivalent metals were screened and only Fe(II) 
showed ligand binding (Figure 3.3). We then began a collaboration with Dr. Timothy 
Stemmler to further study the Fe(II) binding of Sa2591. Dr. Stemmler has optimized a 
Fe(II) competition binding assay that utilizes mag-fura-2, a metal chelator [78] (Figure 
3.4). This assay was used to determine the stoichiometry of Fe(II) binding and the Kd 
values of the binding event(s). Sa2591 preferentially binds 2 Fe(II) ions with estimated Kd 
values of 4.5 ± 1.0 µM and 11.2 ± 3.7 µM (Figure 3.5). We also collected full Fe-XAS of 
Sa2591 loaded with 2 Fe(II) ions. XANES confirmed the oxidation state of the bound irons 
as Fe(II), and not Fe(III), and clearly demonstrate that the Fe(II) is in a symmetric six-
coordinate system with an octahedral geometry (Figure 3.6 and Table 3.1). EXAFS 
showed that the Fe(II) center is bound to O/N ligands, without sulfur coordination in 
contrast to our expectations from the model of Sa2591 (Figure 3.7 and Table 3.2). CD 
spectroscopy showed that the secondary structure of Sa2591 did not change upon Fe(II) 
binding (Figure 3.8 and Table 3.3).  
 Recently, through comparative genomics, Sa2591 was identified for its role in the 
reduction of epoxyqueuosine to queuosine [48]. The authors renamed Sa2591 to QueH, 
an epoxyqueuosine reductase [48]. We hypothesized that QueH would use the 2 Fe(II) 
ions for this reduction. However, after testing several different reaction conditions, we did 
not see any evidence of epoxyqueuosine reductase activity (Figure 3.9). These results, 
along with the XAS data, prompted us to resubmit the S. aureus QueH sequence to I-
TASSER [47]. This time I-TASSER used a tRNA modifying enzyme, 2-thiouridine 
synthetase (TtuA), to build the model of S. aureus QueH. Like QueH, TtuA contains a 
CXXC motif near a P-loop ATPase domain. The crystal structure of TtuA revealed a [4Fe-
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4S] iron-sulfur cluster that is coordinated by its two cysteines in a CXXC motif and another 
cysteine in the protein (Figure 3.10) [46]. The apparent structural similarities between 
TtuA and QueH offer an explanation for why XAS did not show any coordination to sulfur 
and why the epoxyqueuosine reductase assays were unsuccessful. It seems probable 
that QueH requires an iron-sulfur cluster to reduce epoxyqueuosine to queuosine. Future 
experiments would include reconstitution of an [4Fe-4S] iron-sulfur cluster and redoing 
XAS, CD, and the epoxyqueuosine reductase assays.  
 Clearly, QueH appears to be a busy protein involved in multiple, different aspects of 
tRNA biology, namely indirect tRNA aminoacylation and queuosine biosynthesis. We 
hypothesize that QueH uses its two different activities under different growing 
environments (Figure 5.1). Under robust growth conditions, QueH is used for stable 
transamidosome complex formation, enhancing Asn-tRNAAsn biosynthesis and ensuring 
accurate translation of asparagine codons. Under stress, QueH might leave the 
transamidosome or simply fail to activate it, with two different results. First, the rate of 
Asn-tRNAAsn biosynthesis will decrease, leading to aspartate insertion at asparagine 
codons. This hypothesis is supported by the observation that mutations in M. smegmatis 
GatCAB cause mistranslation of aspartate at asparagine codons, which resulted in a 
adaptive phenotype that increased antibiotic tolerance [25, 26]. Second, dissociation or 
deactivation of the transamidosome could allow QueH to turn on its epoxyqueuosine 
reductase activity. This hypothesis is supported by growing evidence that the biosynthesis 
of modified nucleotides in tRNA increases under stress-induced environments, especially 
for modified nucleotides in the wobble position of the anticodon, where queuosine is 
located [98]. Consistently, a study that investigated mRNA turnover in response to pH 
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changes in S. aureus determined that QueH (Sa2591) mRNA transcripts increased during 
acid-shock [99]. S. aureus QueH has proven to be a complicated protein that has several 
different activities with the common theme of interacting with tRNA.  
Figure 5.1. Schematic of our hypothesis that QueH is a multifunctional protein that 
responds to stress. In a healthy growth environment, QueH would be required for the 
stable formation of an Asn-transamidosome, which would increase Asn-tRNAAsn 
biosynthesis and accurate translation. During stress, QueH would leave the 
transamidosome (or stop activating it), which would cause accumulation of Asp-tRNAAsn, 
resulting in Asp insertion at Asn codons. QueH would then use its epoxyqueuosine 
reductase activity to increase queuosine biosynthesis. 
QueH 
ND-AspRS 
GatCAB 
à Asn-tRNAAsn biosynthesis 
Asn-transamidosome disassembly  Queuosine biosynthesis increases 
ND-AspRS GatCAB 
Asp insertion  
at Asn codons 
à
QueH 
Queuosine  
biosynthesis 
+ 2 Fe2+ à
QueH 
Healthy growing 
environment 
Stressful growing 
environment? 
Asn-transamidosome complex formation  
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5.3 Many aminoacyl-tRNA synthetases produce ADP in the presence of deacylated 
tRNAs 
 The aaRSs catalyze tRNA aminoacylation in an ATP dependent manner, releasing 
AMP and PPi as side products. This reaction has long been understood and, to our 
knowledge, production of ADP by the aaRSs has never been reported. In Chapter 4 of 
this thesis, we demonstrated that many of the aaRSs can catalyze the hydrolysis of ATP 
to ADP and Pi in the presence of deacylated tRNA.  
 We recently discovered this activity serendipitously when using H. pylori GluRS2 with 
tRNAGln and glutamate to produce AMP as a positive control on a TLC (Figure 4.1). We 
then tested for this activity with H. pylori GluRS1; here we observed that ADP production 
is stimulated by deacylated tRNAs (Figure 4.2). To investigate if this activity is ubiquitous 
among the aaRSs or restricted to those involved in indirect tRNA aminoacylation, 25 
different aaRSs from 3 different bacterial species were screened for ADP production 
including all 20 aaRSs from E. coli. Rates of ADP production varied by ~20-fold across 
the aaRSs that were tested. Several comparisons can be made across the different 
aaRSs and across different species. One of the most interesting observations is the 
comparison of the 20 E. coli aaRSs across the different subclasses (Figure 4.5). The 
aaRSs that most robustly produce ADP in the presence of deacylated tRNA belong in 
subclasses Ia and IIa. It has been proposed that the aaRSs evolved in pairs across the 
two classes, suggesting that ADP production might have evolved early in the evolution of 
the aaRss [57, 87, 88]. Several other interesting comparisons of the rates of ADP 
production were discussed in Chapter 4 as well as a few possible explanations for this 
activity. There is the tantalizing possibility that this activity may be connected to bacterial 
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persister cell formation. There have been several recent reports that the intracellular ATP 
concentration drops during persister formation, with a concomitant increase in ADP [91-
93]. Perhaps, when the concentration of deacylated tRNAs rises in the cell, indicating a 
nutrient deficient environment, the aaRSs bind to the deacylated tRNA and begin to 
hydrolyze ATP to ADP and Pi, causing the observed dro p in intracellular ATP. 
Importantly, the ADP assays presented herein represent simple snapshots of ADP 
production at single tRNA concentrations. Future experiments could include full kinetic 
analyses for the ADP production with clearly defined tRNA concentrations. Another 
interesting experiment would be to test non-cognate amino acids to see if there is a 
connection to editing and ADP production. 
5.4 Conclusions  
In conclusion, this thesis describes two different research projects that both involved 
tRNA aminoacylation. Chapters 2 and 3 focused on Sa2591, its role in indirect tRNA 
aminoacylation, and its probable role in tRNA modification as an epoxyqueuosine 
reductase. In chapter 4, we show a new activity of the aaRSs: that they are able to 
produce ADP in the presence of deacylated tRNAs. This work demonstrates that while 
these are old enzymes that have been studied for more than 6 decades there are still new 
proteins and activities to be discovered.  
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 Protein translation must usually occur with high accuracy for an organism to survive. 
However, Helicobacter pylori, Staphylococcus aureus, and many other microorganisms 
including important human pathogens, lack one or more aminoacyl-tRNA synthetase 
(aaRS), the enzymes that typically aminoacylate tRNAs for ribosomal translation. These 
organisms must use an indirect pathway to aminoacylate some tRNAs. Specifically, H. 
pylori lacks the genes that encode for asparaginyl- and glutaminyl-tRNA synthetases 
(AsnRS and GlnRS, respectively). Instead, H. pylori uses a two-step, indirect pathway to 
synthesize Asn-tRNAAsn and Gln-tRNAGln. This process requires two misacylating tRNA 
synthetases (a non-discriminating aspartyl-tRNA synthetase, ND-AspRS, and a 
misacylating glutamyl-tRNA synthetase 2, GluRS2) and a glutamine-dependent 
amidotransferase called GatCAB. We have recently discovered a protein called Hp0100 
that promotes formation of a stable complex between ND-AspRS, Hp0100, and GatCAB 
called the Asn-transamidosome. Hp0100 enhances GatCAB’s ability to produce both 
Asn-tRNAAsn and Gln-tRNAGln and it hydrolyzes ATP in the presence of either Asp-
tRNAAsn or Glu-tRNAGln, the precursors to Asn-tRNAAsn and Gln-tRNAGln, respectively. 
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(Red text indicates misacylation.) This dissertation focuses on three different research 
projects. Chapter 2 describes our evaluation of a shortened ortholog of Hp0100 from S. 
aureus. Full-length orthologs of Hp0100 are restricted to the e-proteobacteria; however, 
we have recently discovered truncated orthologs comprising the N-terminal 2/3 of Hp0100 
outside of this clade. The truncated ortholog from S. aureus (Sa2591) is compared to 
Hp0100 to assess if it is a functional ortholog of Hp0100. The predicated model structure 
of Sa2591 showed several conserved cysteine residues clustered together with a CXXC 
motif next to one of the ATPase active sites. Chapter 3 focuses on our characterization 
of this putative metal-binding site and Sa2591’s potential involvement in the synthesis of 
a tRNA modification. Chapter 4 reports our discovery that some aaRSs hydrolyze ATP to 
ADP in the presence of tRNA. All aminoacyl-tRNA synthetases (aaRSs) catalyze the ATP-
dependent aminoacylation of tRNAs, producing AMP and PPi as side products. We are 
unaware of any evidence that aaRSs can produce ADP instead of AMP. We characterized 
this activity in 25 different aaRSs and propose a function for ADP formation. 
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